0000914025April 22022Q1falseP6Mzero00009140252021-04-042021-07-03xbrli:shares00009140252021-07-26iso4217:USD00009140252021-07-0300009140252021-04-030000914025us-gaap:ProductMember2021-04-042021-07-030000914025us-gaap:ProductMember2020-03-292020-06-270000914025us-gaap:ServiceMember2021-04-042021-07-030000914025us-gaap:ServiceMember2020-03-292020-06-2700009140252020-03-292020-06-27iso4217:USDxbrli:shares00009140252020-03-2800009140252020-06-270000914025us-gaap:CommonStockMember2021-04-030000914025us-gaap:AdditionalPaidInCapitalMember2021-04-030000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-030000914025us-gaap:RetainedEarningsMember2021-04-030000914025us-gaap:TreasuryStockMember2021-04-030000914025us-gaap:RetainedEarningsMember2021-04-042021-07-030000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-04-042021-07-030000914025us-gaap:CommonStockMember2021-04-042021-07-030000914025us-gaap:AdditionalPaidInCapitalMember2021-04-042021-07-030000914025us-gaap:TreasuryStockMember2021-04-042021-07-030000914025us-gaap:CommonStockMember2021-07-030000914025us-gaap:AdditionalPaidInCapitalMember2021-07-030000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-07-030000914025us-gaap:RetainedEarningsMember2021-07-030000914025us-gaap:TreasuryStockMember2021-07-030000914025us-gaap:CommonStockMember2020-03-280000914025us-gaap:AdditionalPaidInCapitalMember2020-03-280000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-280000914025us-gaap:RetainedEarningsMember2020-03-280000914025us-gaap:TreasuryStockMember2020-03-280000914025us-gaap:RetainedEarningsMember2020-03-292020-06-270000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-03-292020-06-270000914025us-gaap:CommonStockMember2020-03-292020-06-270000914025us-gaap:AdditionalPaidInCapitalMember2020-03-292020-06-270000914025us-gaap:TreasuryStockMember2020-03-292020-06-270000914025us-gaap:CommonStockMember2020-06-270000914025us-gaap:AdditionalPaidInCapitalMember2020-06-270000914025us-gaap:AccumulatedOtherComprehensiveIncomeMember2020-06-270000914025us-gaap:RetainedEarningsMember2020-06-270000914025us-gaap:TreasuryStockMember2020-06-270000914025us-gaap:CashMember2021-07-030000914025us-gaap:FairValueInputsLevel1Memberpoly:MutualFundsMember2021-07-030000914025us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2021-07-030000914025us-gaap:CashMember2021-04-030000914025us-gaap:FairValueInputsLevel1Memberpoly:MutualFundsMember2021-04-030000914025us-gaap:FairValueInputsLevel1Memberus-gaap:MoneyMarketFundsMember2021-04-030000914025us-gaap:ShortTermInvestmentsMemberpoly:MutualFundsMember2021-07-030000914025us-gaap:OtherNoncurrentLiabilitiesMember2021-07-030000914025us-gaap:OtherNoncurrentLiabilitiesMember2021-04-030000914025poly:ProvisionForPromotionsRebatesAndOtherMember2021-07-030000914025poly:ProvisionForPromotionsRebatesAndOtherMember2021-04-030000914025poly:ProvisionForDoubtfulAccountsAndSalesAllowancesMember2021-07-030000914025poly:ProvisionForDoubtfulAccountsAndSalesAllowancesMember2021-04-030000914025us-gaap:TechnologyBasedIntangibleAssetsMember2021-07-030000914025us-gaap:TechnologyBasedIntangibleAssetsMember2021-04-042021-07-030000914025us-gaap:TechnologyBasedIntangibleAssetsMember2021-04-030000914025us-gaap:CustomerRelationshipsMember2021-07-030000914025us-gaap:CustomerRelationshipsMember2021-04-042021-07-030000914025us-gaap:CustomerRelationshipsMember2021-04-030000914025us-gaap:TradeNamesMember2021-07-030000914025us-gaap:TradeNamesMember2021-04-042021-07-030000914025us-gaap:TradeNamesMember2021-04-030000914025us-gaap:LiabilityMember2021-07-03xbrli:pure0000914025us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMemberus-gaap:FairValueInputsLevel2Member2021-07-030000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-07-030000914025us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMemberus-gaap:FairValueInputsLevel2Member2021-04-030000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Member2021-04-030000914025us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberpoly:SeniorNotes5.50PercentMemberus-gaap:FairValueInputsLevel2Member2021-07-030000914025us-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberpoly:SeniorNotes5.50PercentMemberus-gaap:FairValueInputsLevel2Member2021-07-030000914025us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:SeniorNotesMemberpoly:SeniorNotes5.50PercentMemberus-gaap:FairValueInputsLevel2Member2021-04-030000914025us-gaap:SeniorNotesMemberus-gaap:CarryingReportedAmountFairValueDisclosureMemberpoly:SeniorNotes5.50PercentMemberus-gaap:FairValueInputsLevel2Member2021-04-030000914025us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-07-030000914025us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-07-030000914025us-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-04-030000914025us-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:FairValueInputsLevel2Memberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-04-030000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMember2021-03-040000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMember2021-03-012021-03-310000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes5.50PercentMember2015-05-310000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMembersrt:MinimumMember2021-03-042021-03-040000914025srt:MaximumMemberus-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMember2021-03-042021-03-040000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes475PercentMember2021-03-042021-03-040000914025us-gaap:SeniorNotesMemberpoly:SeniorNotes5.50PercentMember2015-05-012015-05-310000914025poly:SeniorNotes5.50PercentMember2021-05-172021-05-170000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2018-07-020000914025us-gaap:SecuredDebtMember2018-07-0200009140252018-07-022018-07-020000914025poly:FederalFundsRateMemberus-gaap:SecuredDebtMember2020-03-292020-12-260000914025us-gaap:LondonInterbankOfferedRateLIBORMemberus-gaap:SecuredDebtMember2020-03-292020-12-260000914025srt:MinimumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-03-292020-12-260000914025srt:MaximumMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-03-292020-12-260000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-03-292020-12-260000914025poly:DebtInstrumentPeriodFebruaryTwentyTwentyTwentyThroughDecemberTwentySixTwentyTwentyMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-202020-02-200000914025poly:DebtInstrumentPeriodDecemberTwentySixTwentyTwentyandThereafterMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-202020-02-200000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-200000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-202020-02-200000914025us-gaap:LineOfCreditMemberpoly:DebtInstrumentPeriodDecemberTwentyNineTwentyNineteenThroughMarchTwentyEightTwentyTwentyMemberus-gaap:RevolvingCreditFacilityMember2020-02-200000914025poly:DebtInstrumentPeriodMarchTwentyNineTwentyTwentyThroughJuneTwentySevenTwentyTwentyMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-200000914025poly:DebtInstrumentPeriodJuneTwentyEightTwentyTwentyThroughDecemberTwentySixTwentyTwentyMemberus-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2020-02-2000009140252020-12-262020-12-26poly:letter_of_credit0000914025us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2021-07-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:EmployeeSeveranceMember2021-04-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:EmployeeSeveranceMember2021-04-042021-07-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:EmployeeSeveranceMember2021-07-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:FacilityClosingMember2021-04-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:FacilityClosingMember2021-04-042021-07-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:FacilityClosingMember2021-07-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:OtherRestructuringMember2021-04-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:OtherRestructuringMember2021-04-042021-07-030000914025poly:FiscalYear2022RestructuringPlansMemberus-gaap:OtherRestructuringMember2021-07-030000914025poly:FiscalYear2022RestructuringPlansMember2021-04-030000914025poly:FiscalYear2022RestructuringPlansMember2021-04-042021-07-030000914025poly:FiscalYear2022RestructuringPlansMember2021-07-030000914025us-gaap:EmployeeSeveranceMemberpoly:FiscalYear2021RestructuringPlansMember2021-04-030000914025us-gaap:EmployeeSeveranceMemberpoly:FiscalYear2021RestructuringPlansMember2021-04-042021-07-030000914025us-gaap:EmployeeSeveranceMemberpoly:FiscalYear2021RestructuringPlansMember2021-07-030000914025us-gaap:FacilityClosingMemberpoly:FiscalYear2021RestructuringPlansMember2021-04-030000914025us-gaap:FacilityClosingMemberpoly:FiscalYear2021RestructuringPlansMember2021-04-042021-07-030000914025us-gaap:FacilityClosingMemberpoly:FiscalYear2021RestructuringPlansMember2021-07-030000914025us-gaap:OtherRestructuringMemberpoly:FiscalYear2021RestructuringPlansMember2021-04-030000914025us-gaap:OtherRestructuringMemberpoly:FiscalYear2021RestructuringPlansMember2021-04-042021-07-030000914025us-gaap:OtherRestructuringMemberpoly:FiscalYear2021RestructuringPlansMember2021-07-030000914025poly:FiscalYear2021RestructuringPlansMember2021-04-030000914025poly:FiscalYear2021RestructuringPlansMember2021-04-042021-07-030000914025poly:FiscalYear2021RestructuringPlansMember2021-07-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:EmployeeSeveranceMember2021-04-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:EmployeeSeveranceMember2021-04-042021-07-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:EmployeeSeveranceMember2021-07-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:FacilityClosingMember2021-04-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:FacilityClosingMember2021-04-042021-07-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:FacilityClosingMember2021-07-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:OtherRestructuringMember2021-04-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:OtherRestructuringMember2021-04-042021-07-030000914025poly:FiscalYear2020RestructuringPlansMemberus-gaap:OtherRestructuringMember2021-07-030000914025poly:FiscalYear2020RestructuringPlansMember2021-04-030000914025poly:FiscalYear2020RestructuringPlansMember2021-04-042021-07-030000914025poly:FiscalYear2020RestructuringPlansMember2021-07-030000914025us-gaap:EmployeeSeveranceMember2021-04-030000914025us-gaap:EmployeeSeveranceMember2021-04-042021-07-030000914025us-gaap:EmployeeSeveranceMember2021-07-030000914025us-gaap:FacilityClosingMember2021-04-030000914025us-gaap:FacilityClosingMember2021-04-042021-07-030000914025us-gaap:FacilityClosingMember2021-07-030000914025us-gaap:OtherRestructuringMember2021-04-030000914025us-gaap:OtherRestructuringMember2021-04-042021-07-030000914025us-gaap:OtherRestructuringMember2021-07-030000914025us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-07-030000914025us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember2021-04-030000914025us-gaap:AccumulatedTranslationAdjustmentMember2021-07-030000914025us-gaap:AccumulatedTranslationAdjustmentMember2021-04-03poly:financial_institution0000914025us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2021-07-030000914025us-gaap:OtherCurrentAssetsMemberus-gaap:NondesignatedMember2021-04-030000914025us-gaap:CashFlowHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-030000914025us-gaap:CashFlowHedgingMemberus-gaap:OtherCurrentAssetsMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-030000914025us-gaap:OtherCurrentAssetsMemberus-gaap:InterestRateSwapMember2021-07-030000914025us-gaap:OtherCurrentAssetsMemberus-gaap:InterestRateSwapMember2021-04-030000914025us-gaap:OtherCurrentAssetsMember2021-07-030000914025us-gaap:OtherCurrentAssetsMember2021-04-030000914025us-gaap:OtherLiabilitiesMemberus-gaap:NondesignatedMember2021-07-030000914025us-gaap:OtherLiabilitiesMemberus-gaap:NondesignatedMember2021-04-030000914025us-gaap:CashFlowHedgingMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-07-030000914025us-gaap:CashFlowHedgingMemberus-gaap:OtherLiabilitiesMemberus-gaap:DesignatedAsHedgingInstrumentMember2021-04-030000914025us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateSwapMember2021-07-030000914025us-gaap:OtherLiabilitiesMemberus-gaap:InterestRateSwapMember2021-04-030000914025us-gaap:OtherLiabilitiesMember2021-07-030000914025us-gaap:OtherLiabilitiesMember2021-04-03iso4217:EUR0000914025poly:ForeignExchangeForwardEuroMember2021-07-030000914025poly:ForeignExchangeForwardEuroMember2021-04-042021-07-03iso4217:GBP0000914025poly:ForeignExchangeForwardGbpMember2021-07-030000914025poly:ForeignExchangeForwardGbpMember2021-04-042021-07-030000914025us-gaap:NondesignatedMember2021-04-042021-07-030000914025us-gaap:NondesignatedMember2020-03-292020-06-270000914025us-gaap:CashFlowHedgingMembersrt:MinimumMemberus-gaap:OptionMember2021-04-042021-07-030000914025us-gaap:CashFlowHedgingMembersrt:MaximumMemberus-gaap:OptionMember2021-04-042021-07-030000914025us-gaap:CashFlowHedgingMemberus-gaap:ForwardContractsMember2021-04-042021-07-030000914025us-gaap:ForeignExchangeOptionMember2021-07-030000914025us-gaap:ForeignExchangeOptionMember2021-04-030000914025us-gaap:ForeignExchangeForwardMember2021-07-030000914025us-gaap:ForeignExchangeForwardMember2021-04-03iso4217:MXN0000914025poly:ForeignCurrencySwapContractMember2021-07-030000914025poly:ForeignCurrencySwapContractMember2021-04-030000914025us-gaap:InterestRateSwapMember2021-06-152021-06-150000914025us-gaap:InterestRateSwapMember2021-06-150000914025us-gaap:InterestRateSwapMember2018-07-302018-07-300000914025us-gaap:InterestRateSwapMember2018-07-300000914025us-gaap:InterestRateSwapMember2021-04-042021-07-030000914025us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2021-04-042021-07-030000914025us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember2020-03-292020-06-270000914025poly:HeadsetMember2021-04-042021-07-030000914025poly:HeadsetMember2020-03-292020-06-270000914025poly:VoiceMember2021-04-042021-07-030000914025poly:VoiceMember2020-03-292020-06-270000914025poly:VideoMember2021-04-042021-07-030000914025poly:VideoMember2020-03-292020-06-270000914025us-gaap:ProductMembercountry:US2021-04-042021-07-030000914025us-gaap:ProductMembercountry:US2020-03-292020-06-270000914025us-gaap:ProductMemberus-gaap:EMEAMember2021-04-042021-07-030000914025us-gaap:ProductMemberus-gaap:EMEAMember2020-03-292020-06-270000914025us-gaap:ProductMembersrt:AsiaPacificMember2021-04-042021-07-030000914025us-gaap:ProductMembersrt:AsiaPacificMember2020-03-292020-06-270000914025poly:AmericasexcludingUnitedStatesMemberus-gaap:ProductMember2021-04-042021-07-030000914025poly:AmericasexcludingUnitedStatesMemberus-gaap:ProductMember2020-03-292020-06-270000914025us-gaap:ProductMemberpoly:AllCountriesExceptUnitedStatesMember2021-04-042021-07-030000914025us-gaap:ProductMemberpoly:AllCountriesExceptUnitedStatesMember2020-03-292020-06-270000914025us-gaap:ServiceMembercountry:US2021-04-042021-07-030000914025us-gaap:ServiceMembercountry:US2020-03-292020-06-270000914025us-gaap:ServiceMemberus-gaap:EMEAMember2021-04-042021-07-030000914025us-gaap:ServiceMemberus-gaap:EMEAMember2020-03-292020-06-270000914025us-gaap:ServiceMembersrt:AsiaPacificMember2021-04-042021-07-030000914025us-gaap:ServiceMembersrt:AsiaPacificMember2020-03-292020-06-270000914025us-gaap:ServiceMemberpoly:AmericasexcludingUnitedStatesMember2021-04-042021-07-030000914025us-gaap:ServiceMemberpoly:AmericasexcludingUnitedStatesMember2020-03-292020-06-270000914025us-gaap:ServiceMemberpoly:AllCountriesExceptUnitedStatesMember2021-04-042021-07-030000914025us-gaap:ServiceMemberpoly:AllCountriesExceptUnitedStatesMember2020-03-292020-06-27poly:segment0000914025us-gaap:OperatingSegmentsMemberpoly:ProductsSegmentMember2021-04-042021-07-030000914025us-gaap:OperatingSegmentsMemberpoly:ProductsSegmentMember2020-03-292020-06-270000914025poly:ServicesSegmentMemberus-gaap:OperatingSegmentsMember2021-04-042021-07-030000914025poly:ServicesSegmentMemberus-gaap:OperatingSegmentsMember2020-03-292020-06-270000914025us-gaap:OperatingSegmentsMember2021-04-042021-07-030000914025us-gaap:OperatingSegmentsMember2020-03-292020-06-270000914025us-gaap:MaterialReconcilingItemsMember2021-04-042021-07-030000914025us-gaap:MaterialReconcilingItemsMember2020-03-292020-06-2700009140252020-09-272020-12-26

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended July 3, 2021
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________to _________

Commission File Number: 001-12696

POLY-20210703_G1.JPG
Plantronics, Inc.
(Exact name of registrant as specified in its charter)
Delaware 77-0207692
(State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.)

345 Encinal Street
Santa Cruz, California 95060
(Address of principal executive offices)
(Zip Code)

(831) 420-3002
(Registrant's telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.01 par value POLY New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

1


Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of July 26, 2021, 42,321,794 shares of the registrant's common stock were outstanding.
2


PLANTRONICS, INC.
FORM 10-Q
TABLE OF CONTENTS
Page
PART I FINANCIAL INFORMATION
4
4
5
6
7
9
10
28
29
31
36
38
38
39
41
PART II OTHER INFORMATION  
41
41
42
43
44

Plantronics, Poly, the Propeller design, the Poly logo, and Polycom are trademarks of Plantronics, Inc.
All other trademarks are the property of their respective owners.
3

Table of Contents
PART I - FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

PLANTRONICS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
(Unaudited)
July 3, 2021 April 3,
2021
ASSETS    
Current assets    
Cash and cash equivalents $ 196,761  $ 202,560 
Restricted cash —  493,908 
Short-term investments 15,953  14,559 
Accounts receivable, net 271,592  267,464 
Inventory, net 187,476  194,405 
Other current assets 61,974  65,214 
Total current assets 733,756  1,238,110 
Non-current assets
Property, plant, and equipment, net 131,294  140,875 
Purchased intangibles, net 311,180  341,614 
Goodwill 796,216  796,216 
Deferred tax assets 101,841  95,800 
Other non-current assets 60,774  51,654 
Total assets $ 2,135,061  $ 2,664,269 
LIABILITIES AND STOCKHOLDERS' DEFICIT    
Current liabilities    
Accounts payable $ 163,926  $ 151,244 
Accrued liabilities 361,940  394,084 
Current portion of long-term debt —  478,807 
Total current liabilities 525,866  1,024,135 
Non-current liabilities
Long-term debt, net 1,497,119  1,496,064 
Long-term income taxes payable 85,858  86,227 
Other non-current liabilities 138,772  138,609 
Total liabilities 2,247,615  2,745,035 
Commitments and contingencies (Note 7)
Stockholders' deficit    
Common stock 921  912 
Additional paid-in capital 1,566,688  1,556,272 
Accumulated other comprehensive income (loss) 1,602  (3,221)
Accumulated deficit (802,044) (765,233)
Total stockholders' equity before treasury stock 767,167  788,730 
Less: Treasury stock, at cost (879,721) (869,496)
Total stockholders' deficit (112,554) (80,766)
Total liabilities and stockholders' deficit $ 2,135,061  $ 2,664,269 

The accompanying notes are an integral part of these condensed consolidated financial statements.
4

Table of Contents
PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)
Three Months Ended
  July 3, 2021 June 27, 2020
Net revenues
Net product revenues $ 371,203  $ 291,458 
Net service revenues 59,969  64,262 
Total net revenues 431,172  355,720 
Cost of revenues
Cost of product revenues 235,196  176,615 
Cost of service revenues 20,787  22,773 
Total cost of revenues 255,983  199,388 
Gross profit 175,189  156,332 
Operating expenses
Research, development, and engineering 45,466  50,029 
Selling, general, and administrative 120,734  116,644 
Loss, net from litigation settlements —  17,561 
Restructuring and other related charges 28,972  29,330 
Total operating expenses 195,172  213,564 
Operating loss (19,983) (57,232)
Interest expense 21,782  21,184 
Other non-operating income, net (692) (224)
Loss before income taxes (41,073) (78,192)
Income tax benefit (4,262) (3,177)
Net loss $ (36,811) $ (75,015)
Per share data
Basic and diluted loss per common share $ (0.88) $ (1.85)
Basic and diluted shares used in computing loss per common share 42,061  40,460 

The accompanying notes are an integral part of these condensed consolidated financial statements.
5

Table of Contents
PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
(in thousands)
(Unaudited)
Three Months Ended
July 3, 2021 June 27, 2020
Net loss $ (36,811) $ (75,015)
Other comprehensive income, before tax
Unrealized gains on cash flow hedges
Unrealized cash flow hedge gains (losses) 440  (1,579)
Net losses (gains) reclassified into net revenues 1,772  (909)
Net gains reclassified into cost of revenues (236) — 
Net losses reclassified into interest expense 3,089  3,723 
Net unrealized gains on cash flow hedges 5,065  1,235 
Income tax (expense) benefit in other comprehensive income (243) 264 
Other comprehensive income 4,822  1,499 
Comprehensive loss $ (31,989) $ (73,516)

The accompanying notes are an integral part of these condensed consolidated financial statements.
6

Table of Contents
PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
Three Months Ended
  July 3, 2021 June 27, 2020
Cash flows from operating activities    
Net loss $ (36,811) $ (75,015)
Adjustments to reconcile net loss to net cash provided by operating activities
Depreciation and amortization 39,833  43,400 
Amortization of debt issuance costs 2,937  1,340 
Stock-based compensation 10,416  9,355 
Deferred income taxes (5,943) (7,169)
Provision for excess and obsolete inventories 5,310  6,082 
Restructuring and other related charges 28,972  29,330 
Cash payments for restructuring charges (12,230) (13,085)
Other operating activities (2,998) (1,851)
Changes in assets and liabilities  
Accounts receivable, net (3,758) 37,914 
Inventory, net 6,326  (16,008)
Current and other assets 365  3,483 
Accounts payable 12,515  12,321 
Accrued liabilities (40,631) 11,236 
Income taxes (3,454) 389 
Net cash provided by operating activities 849  41,722 
Cash flows from investing activities  
Purchases of short-term investments (404) (108)
Capital expenditures (6,052) (5,437)
Proceeds from sale of property and equipment —  1,900 
Other investing activities (4,000) — 
Cash used in investing activities (10,456) (3,645)
Cash flows from financing activities  
Employees' tax withheld and paid for restricted stock and restricted stock units (10,225) (2,739)
Proceeds from issuances under stock-based compensation plans
Proceeds from revolving line of credit —  50,000 
Repayments of revolving line of credit —  (50,000)
Repayments of long-term debt (480,689) — 
Net cash used in financing activities (490,905) (2,734)
Effect of exchange rate changes on cash and cash equivalents and restricted cash 805  544 
Net (decrease) increase in cash and cash equivalents and restricted cash (499,707) 35,887 
Cash and cash equivalents and restricted cash at beginning of period 696,468  213,879 
Cash and cash equivalents and restricted cash at end of period $ 196,761  $ 249,766 

The accompanying notes are an integral part of these condensed consolidated financial statements.
7

Table of Contents
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same amounts shown in the condensed consolidated statements of cash flows:

(in thousands) July 3, 2021 April 3, 2021
Cash and cash equivalents $ 196,761  $ 202,560 
Restricted cash —  493,908 
Total cash, cash equivalents, and restricted cash shown in the condensed consolidated statements of cash flows $ 196,761  $ 696,468 
8

Table of Contents
PLANTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT
(in thousands)
(Unaudited)
Three Months Ended July 3, 2021
  Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Income (Loss) Accumulated Deficit Treasury Stock Total Stockholders' Deficit
  Shares Amount
Balances at April 3, 2021 41,751  $ 912  $ 1,556,272  $ (3,221) $ (765,233) $ (869,496) $ (80,766)
Net loss —  —  —  —  (36,811) —  (36,811)
Net unrealized gains on cash flow hedges, net of tax —  —  —  4,823  —  —  4,823 
Proceeds from issuances under stock-based compensation plans 569  —  —  —  — 
Stock-based compensation —  —  10,416  —  —  —  10,416 
Employees' tax withheld and paid for restricted stock and restricted stock units —  —  —  —  —  (10,225) (10,225)
Balances at July 3, 2021 42,320  $ 921  $ 1,566,688  $ 1,602  $ (802,044) $ (879,721) $ (112,554)

Three Months Ended June 27, 2020
  Common Stock Additional Paid-In Capital Accumulated Other Comprehensive Loss Accumulated Deficit Treasury Stock Total Stockholders' Deficit
  Shares Amount
Balances at March 28, 2020 40,406  $ 896  $ 1,501,340  $ (13,582) $ (707,904) $ (863,566) $ (82,816)
Net loss —  —  —  —  (75,015) —  (75,015)
Net unrealized gains on cash flow hedges, net of tax —  —  —  1,499  —  —  1,499 
Proceeds from issuances under stock-based compensation plans 519  —  —  —  — 
Repurchase of restricted common stock (10) —  —  —  —  —  — 
Stock-based compensation —  —  9,355  —  —  —  9,355 
Employees' tax withheld and paid for restricted stock and restricted stock units (233) —  —  —  —  (2,739) (2,739)
Balances at June 27, 2020 40,682  $ 901  $ 1,510,695  $ (12,083) $ (782,919) $ (866,305) $ (149,711)

The accompanying notes are an integral part of these condensed consolidated financial statements.
9

Table of Contents
PLANTRONICS, INC.
NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)

1. BACKGROUND AND BASIS OF PRESENTATION

Plantronics, Inc. (“Poly,” the “Company”) is a leading global communications company that designs, manufactures, and markets integrated communications and collaboration solutions that span headsets, open Session Initiation Protocol ("SIP") and native ecosystem desktop phones, conference room phones, video conferencing solutions and peripherals, including cameras, speakers, and microphones, cloud management and analytics software solutions, and services. The Company has two operating and reportable segments, Products and Services, and offers its products under the POLY-20210703_G2.JPG , Plantronics and Polycom brands.

Founded in 1961, the Company is incorporated in the state of Delaware under the name Plantronics, Inc. and in March 2019, the Company changed the name under which it markets itself to Poly. The Company is listed on the New York Stock Exchange ("NYSE") under the ticker symbol "POLY."

The accompanying unaudited condensed consolidated financial statements of the Company have been prepared on a basis materially consistent with and should be reviewed in conjunction with the Company's audited consolidated financial statements as of and for the year ended April 3, 2021 and notes thereto included in the Company's Annual Report on Form 10-K, which was filed with the Securities and Exchange Commission ("SEC") on May 18, 2021 and include all adjustments necessary to fairly state the information set forth herein. Certain information and footnote disclosures normally included in financial statements prepared pursuant to the rules and regulations of the SEC applicable to interim financial information and in accordance with accounting principles generally accepted in the United States of America ("GAAP") have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements contain all adjustments necessary for a fair presentation of the Company’s consolidated financial position and the consolidated results of operations and cash flows as of the dates and for the periods presented and are normal and recurring in nature The Company's reporting currency is United States Dollars ("USD.") The interim period results are subject to variation and are not necessarily indicative of the results of operations to be expected for the full fiscal year. The financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany balances and transactions have been eliminated.

The Company’s fiscal year ends on the Saturday closest to the last day of March. The Company’s current fiscal year ends on April 2, 2022 and consists of 52 weeks. The Company's prior fiscal year ended on April 3, 2021 and consisted of 53 weeks. The three months ended July 3, 2021 and June 27, 2020 both contain 13 weeks.

Risks and uncertainties

The Company is subject to a greater degree of uncertainty than normal in making the judgments and estimates needed to apply its significant accounting policies due to the ongoing COVID-19 pandemic. The Company has assessed accounting estimates and other matters, including those using prospective financial information, using information that is reasonably available as of the issuance date of the consolidated financial statements. The accounting estimates and other matters the Company has assessed included, but were not limited to, impairment of goodwill and other long-lived assets, provisions for doubtful accounts, valuation allowances for deferred tax assets, inventory and related reserves, and revenue recognition and related reserves. The Company may make changes to these estimates and judgments, which could result in material impacts to the consolidated financial statements in future periods. The extent and duration of the impact of the COVID-19 pandemic on the Company's business is highly uncertain and difficult to predict. The Company relies on contract manufacturers and sourcing of materials from the Asia Pacific region, as well as its owned manufacturing facility in Mexico. The Company has experienced disruptions in both its own supply chain as well as those of its contract manufacturers as a result of COVID-19 and, as this virus has impacted various regions differently, the Company may in the future experience further business operation disruptions. Such disruptions have had, and may continue to have, a material impact on the Company's ability to fulfill customer orders and adversely affect the ability to meet customer demands as companies utilize work-from-home and hybrid work models. Additionally, if a significant number of the Company's workforce employed in any of these manufacturing facilities or in the Company's offices were to contract the virus, the Company may experience delays or the inability to develop, produce and deliver the Company's products on a timely basis. Furthermore, capital markets and economies worldwide have also been negatively impacted by the COVID-19 pandemic, and it is possible that it could cause a local and/or global economic recession.

10

The severity of the impact of the COVID-19 pandemic on the Company's business will depend on a number of factors, including, but not limited to, the duration and severity of the pandemic and the extent and severity of the impact on its customers and suppliers, all of which are uncertain and cannot be predicted. The Company's future results of operations and liquidity could be adversely impacted by delays in payments of outstanding receivable amounts beyond normal payment terms, including potential write-offs due to financial weakness and/or bankruptcy of its customers, supply chain disruptions and uncertain demand, and the impact of any initiatives or programs that the Company may undertake to address financial and operational challenges faced by its customers and suppliers.

As of the issuance date of these condensed consolidated financial statements, the extent to which the COVID-19 pandemic may materially impact the Company's financial condition, liquidity, or results of operations is uncertain.

Reclassifications

Certain prior year amounts have been reclassified for consistency with current year presentation. Each of the reclassifications was immaterial and had no effect on the Company's results of operations or cash flows.

2. RECENT ACCOUNTING PRONOUNCEMENTS

Recent accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") did not and are not expected to have a material impact on the Company's financial position, results of operations, or cash flows.

3. CASH AND CASH EQUIVALENTS, RESTRICTED CASH, AND SHORT-TERM INVESTMENTS

The following tables summarize the Company’s cash and cash equivalents, restricted cash, and short-term investments amortized cost, gross unrealized gains, gross unrealized losses, and fair value on a recurring basis by significant investment category recorded as of July 3, 2021 and April 3, 2021 (in thousands):
July 3, 2021 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Cash & Cash Equivalents Short-term investments
Cash $ 171,751  $ —  $ —  $ 171,751  $ 171,751  $ — 
Level 1:
Mutual funds 13,553  2,401  (1) 15,953  —  15,953 
Money market funds 25,010  —  —  25,010  25,010  — 
Total cash, cash equivalents
and short-term investments measured at fair value
$ 210,314  $ 2,401  $ (1) $ 212,714  $ 196,761  $ 15,953 

April 3, 2021 Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair
Value
Cash & Cash Equivalents Restricted Cash Short-Term Investments
Cash $ 177,551  $ —  $ —  $ 177,551  $ 177,551  $ —  $ — 
Restricted cash(1)
493,908  493,908 493,908 
Level 1:
Mutual funds 12,622  1,945  (8) 14,559  —  14,559 
Money market funds 25,009  —  —  25,009  25,009 
Total cash, cash equivalents, restricted cash and short-term investments measured at fair value $ 709,090  $ 1,945  $ (8) $ 711,027  $ 202,560  $ 493,908  $ 14,559 

(1) Restricted cash represents the cash held in trust and restricted for use to redeem the 5.50% Senior Notes. Refer to Note 8, Debt.

11

As of July 3, 2021 and April 3, 2021, the Company's short-term investments consisted of assets related to its deferred compensation plans and are classified as trading securities. The assets are reported at fair value, with unrealized gains and losses included in current period earnings. For more information regarding the Company's deferred compensation plan, see Note 4, Deferred Compensation. The Company did not incur any material realized or unrealized gains or losses in the three months ended July 3, 2021 or June 27, 2020. There were no transfers between fair value measurement levels during the three months ended July 3, 2021 or June 27, 2020.

4.  DEFERRED COMPENSATION

As of July 3, 2021, the Company held investments in mutual funds with a fair value totaling $16.0 million, all of which related to debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans. The total related deferred compensation liability was $16.0 million at July 3, 2021. As of April 3, 2021, the Company held investments in mutual funds with a fair value totaling $14.6 million, all of which related to debt and equity securities that are held in a rabbi trust under non-qualified deferred compensation plans. The total related deferred compensation liability at April 3, 2021 was $14.6 million.

The investments are classified as trading securities and are recorded in short-term investments in the condensed consolidated balance sheets. The liability is recorded in accrued liabilities and other non-current liabilities in the condensed consolidated balance sheets.

5. DETAILS OF CERTAIN BALANCE SHEET ACCOUNTS

Accounts receivable, net:
(in thousands) July 3, 2021 April 3, 2021
Accounts receivable $ 360,004  $ 352,108 
Provisions for promotions, rebates, and other (86,586) (82,315)
Provisions for doubtful accounts and sales allowances (1,826) (2,329)
Accounts receivable, net $ 271,592  $ 267,464 

The Company maintains a provision for doubtful accounts for estimated losses resulting from the inability of its customers to make required payments. The Company regularly performs credit evaluations of its customers’ financial conditions and considers factors such as historical experience, credit quality, age of the accounts receivable balances, geographic or country-specific risks, and economic conditions that may affect a customer’s ability to pay. 

Inventory, net:
(in thousands) July 3, 2021 April 3, 2021
Raw materials $ 83,420  $ 87,050 
Work in process 4,927  9,511 
Finished goods 99,129  97,844 
Inventory, net $ 187,476  $ 194,405 

Accrued Liabilities:
(in thousands) July 3, 2021 April 3, 2021
Short-term deferred revenue $ 136,433  $ 141,375 
Employee compensation and benefits 61,095  84,318 
Operating lease liabilities, current 20,293  21,701 
Provision for returns 19,011  25,133 
Accrued other 125,108  121,557 
Accrued liabilities $ 361,940  $ 394,084 

12

The Company's warranty obligation is recorded in accrued liabilities in the condensed consolidated balance sheets. Changes in the warranty obligation during the three months ended July 3, 2021 and June 27, 2020 were as follows:
Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Warranty obligation at beginning of period $ 17,384  $ 15,261 
Warranty provision related to products shipped 4,157  9,428 
Deductions for warranty claims processed (6,800) (4,269)
Adjustments related to preexisting warranties 3,603  (533)
Warranty obligation at end of period $ 18,344  $ 19,887 

6.    PURCHASED INTANGIBLE ASSETS

As of July 3, 2021 and April 3, 2021, the carrying value of purchased intangibles, excluding fully amortized assets and goodwill, is as follows:
July 3, 2021 April 3, 2021
(in thousands) Gross Carrying Amount Accumulated Amortization Net Carrying Amount Weighted Average Remaining Useful Life Gross Carrying Amount Accumulated Amortization Net Carrying Amount
Amortizing Assets
Existing technology $ 427,123  $ (293,310) $ 133,813  2.1 years $ 427,123  $ (277,071) $ 150,052 
Customer relationships 240,024  (139,724) 100,300  3.0 years 240,024  (128,740) 111,284 
Trade name/Trademarks 115,600  (38,533) 77,067  6.0 years 115,600  (35,322) 80,278 
Total intangible assets $ 782,747  $ (471,567) $ 311,180  3.3 years $ 782,747  $ (441,133) $ 341,614 

During the three months ended July 3, 2021 and June 27, 2020, the Company recognized amortization expense of $30.4 million and $32.4 million, respectively.

Expected amortization expense attributable to purchased intangibles for each of the next five years and thereafter as of July 3, 2021 is as follows:
(in thousands) Amount
2022 (remaining nine months) $ 83,424 
2023 111,232 
2024 65,936 
2025 21,688 
2026 12,844 
Thereafter 16,056 
$ 311,180 

13

7. COMMITMENTS AND CONTINGENCIES

Future Minimum Lease Payments

Future minimum lease payments under non-cancelable operating leases as of July 3, 2021 were as follows:
(in thousands)
Operating Leases(1)
2022 (remaining nine months) $ 17,939 
2023 10,464 
2024 8,719 
2025 6,791 
2026 5,627 
Thereafter 16,086 
Total lease payments $ 65,626 
Less: Imputed interest(2)
(7,955)
Present value of lease liabilities $ 57,671 
(1) The weighted average remaining lease term was 4.8 years as of July 3, 2021.
(2) The weighted average discount rate was 4.7% as of July 3, 2021.

Unconditional Purchase Obligations

The Company purchases materials and services from a variety of suppliers and manufacturers. During the normal course of business and to manage manufacturing operations, the Company may enter into firm, non-cancelable, and unconditional purchase obligations for inventory, including electronic components, such as semiconductor chips, in addition to service, capital expenditure, and general and administrative activities, for which amounts are not recorded on the condensed consolidated balance sheets.  As of July 3, 2021, the Company had outstanding off-balance sheet third-party manufacturing, component purchase, and other general and administrative commitments of $599.5 million.

Other Guarantees and Obligations

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, purchasers of assets or subsidiaries and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company's breach of agreements or representations and warranties made by the Company, services to be provided by the Company, intellectual property infringement claims made by third parties or, with respect to the sale of assets of a subsidiary, matters related to the Company's conduct of business and tax matters prior to the sale. From time to time, the Company indemnifies customers against combinations of loss, expense, or liability arising from various triggering events relating to the sale and use of its products and services.

In addition, the Company also provides indemnification to customers against claims related to undiscovered liabilities, additional product liability, or environmental obligations. The Company has also entered into indemnification agreements with its directors, officers, and certain other personnel that will require the Company, among other things, to indemnify them against certain liabilities that may arise by reason of their status or service as directors or officers of the Company or certain of its affiliated entities. The Company maintains director and officer liability insurance, which may cover certain liabilities arising from its obligation to indemnify its directors, officers, and certain other personnel in certain circumstances. It is not possible to determine the aggregate maximum potential loss under these agreements due to the limited history of prior claims and the unique facts and circumstances involved in each particular claim. Such indemnification obligations might not be subject to maximum loss clauses. Historically, the Company has not incurred material costs as a result of obligations under these agreements and it has not accrued any liabilities related to such indemnification obligations in the condensed consolidated financial statements.
14


Claims and Litigation

On January 23, 2018, FullView, Inc. filed a complaint in the United States District Court of the Northern District of California against Polycom, Inc. alleging infringement of two patents and thereafter filed a similar complaint in connection with the same patents in Canada. Polycom thereafter filed an inter partes reexamination ("IPR") of one of the patents, which was then appealed to Federal Circuit Court and denied. Litigation in both matters in the United States and Canada, respectively, were stayed pending the results of that appeal. Polycom also filed an IPR of the second patent and the U.S. Patent Trial and Appeal Board (“PTAB”) denied institution of the IPR petition. FullView had also initiated arbitration proceedings under a terminated license agreement with Polycom alleging that Polycom had failed to pay certain royalties due under that agreement. The arbitration panel awarded an immaterial amount to FullView. FullView filed a First and Second Amended Complaint and Polycom filed a motion to dismiss. The Court granted Polycom's partial motion to dismiss without prejudice and invalidated one of the patents in suit. Litigation on the remaining patent is ongoing.

On June 21, 2018, directPacket Research Inc. filed a complaint alleging patent infringement by Polycom, Inc. in the United States District Court for the Eastern District of Virginia, Norfolk Division. The Court granted Polycom’s Motion to Transfer Venue to the Northern District of California. Polycom filed petitions for Inter Partes Review of the asserted patents which were granted by the PTAB. The District Court matter was stayed pending resolution of the IPRs. Oral argument was heard on the IPRs on October 20, 2020. On January 11, 2021, the PTAB issued final written decisions invalidating two of the asserted patents. The remaining claims of the third patent were unasserted against the Company. On February 12, 2021, directPacket filed a notice of appeal to the United States Court of Appeals for the Federal Circuit with respect to the PTAB’s final written decision regarding the ’588 patent. On March 15, 2021, Polycom filed a notice of appeal to the United States Court of Appeals for the Federal Circuit with respect to the PTAB’s final written decision regarding the ’978 patent. Both parties have filed their respective appellate briefs and litigation is ongoing.

On November 15, 2019, Felice Bassuk, individually and on behalf of others similarly situated, filed a complaint against the Company, its former CEO, Joseph Burton, its CFO, Charles Boynton, and its former CFO, Pamela Strayer, alleging various securities law violations. The Company disputes the allegations. The Court appointed lead plaintiff and lead counsel and renamed the action “In re Plantronics, Inc. Securities Litigation” on February 13, 2020. Plaintiffs filed the amended complaint on June 5, 2020 and the Company’s Motion to Dismiss the Amended Complaint on August 7, 2020. Plaintiffs filed their opposition on October 2, 2020 and the Company replied on November 16, 2020. The hearing scheduled for January 13, 2021 was vacated and on March 29, 2021, the Court issued its order granting the Company’s motion to dismiss, but allowing the Plaintiffs leave to amend their complaint. On April 13, 2021, pursuant to the parties’ mutual agreement, the Court issued its order granting a stipulation and scheduling order which provides the plaintiffs until June 15, 2021 (subsequently extended to June 22, 2021) to consider whether or not to file a second amended complaint, and if filed, allowing defendants until August 16, 2021 to file a motion to dismiss, with plaintiffs’ opposition to such motion due on or before September 30, 2021, and with defendants’ reply to be filed on or before November 1, 2021. The Plaintiff filed an amended complaint on June 22, 2021 and the Company expects to file its Motion to Dismiss by the applicable deadline.

On December 17, 2019, Cisco Systems, Inc. filed a First Amended Complaint for Trade Secret Misappropriation against Plantronics, Inc. and certain individuals which amends a previously filed complaint against certain other individuals. The Company disputes the allegations. The Company filed a Motion to Dismiss and the Court granted the such Motion with leave to amend as to defendants He, Chung and Williams, granted the Motion to Compel Arbitration for defendant Williams and granted in part and denied in part the Motion to Dismiss by defendants Puorro and the Company. Cisco filed an Amended Complaint and the defendants moved to dismiss or strike portions of the Amended Complaint. The Court granted in part and denied in part the Motion to Dismiss. On September 10, 2020, the Company filed a Motion for Protective Order and a Motion to Strike and Challenge the Sufficiency of Cisco’s Trade Secret Disclosure. On December 21, 2020, the Court granted in part and denied in part such Motions. On December 30, 2020, Cisco filed a motion for leave to file a Motion for Reconsideration. On January 11, 2021 the Company filed its opposition. The Court issued its Case Management and Pretrial order setting a settlement conference which occurred on April 1, 2021. During such mediation conference, the parties agreed to stay the District Court case for 30 days to pursue settlement of pending claims. This 30 day period has run, and the parties were unable to reach settlement. The litigation is ongoing and discovery continues.
15


On July 22, 2020, Koss Corporation filed a complaint alleging patent infringement by the Company and Polycom, Inc. in the United States District Court for the Western District of Texas, Waco Division. The Company answered the Complaint on October 1, 2020 disputing the claims. On December 18, 2020, the Company filed a Motion to Transfer Venue to the Northern District of California, which remains pending. On January 29, 2021, the plaintiff amended its infringement contentions to add new accused products. On February 12, 2021, the plaintiff filed its opposition to the Motion to Transfer. Claim construction exchanges have begun, and a claim construction hearing was scheduled for April 22, 2021. Trial is scheduled for April 18, 2022. On May 20, 2021, the judge granted the Company’s Motion to Transfer Venue to the Northern District of California. Discovery continues.

In addition to the specific matters discussed above, the Company is involved in various legal proceedings and investigations arising in the normal course of conducting business. Where applicable, in relation to the matters described above, the Company has accrued an amount that reflects the aggregate liability deemed probable and estimable, but this amount is not material to the Company's financial condition, results of operations, or cash flows. The Company is not able to estimate an amount or range of any reasonably possible loss, including in excess of any amount accrued, because of the preliminary nature of many of these proceedings, the difficulty in ascertaining the applicable facts relating to many of these proceedings, the variable treatment of claims made in many of these proceedings, and the difficulty of predicting the settlement value of many of these proceedings.

However, based upon the Company's historical experience, the resolution of these proceedings is not expected to have a material effect on the Company's financial condition, results of operations or cash flows. The Company may incur substantial legal fees, which are expensed as incurred, in defending against these legal proceedings.

8. DEBT

The carrying value and estimated fair value measured on a recurring basis of the Company's outstanding debt as of July 3, 2021 and April 3, 2021 was as follows:
July 3, 2021 April 3, 2021
(in thousands) Fair Value Carrying Value Fair Value Carrying Value
4.75% Senior Notes $ 496,475  $ 494,173  $ 492,580  $ 493,985 
5.50% Senior Notes —  —  482,669  478,807 
Term loan facility 999,659  1,002,946  1,004,743  1,002,079 

As of July 3, 2021 and April 3, 2021, the net unamortized discount, premium, and debt issuance costs on the Company's outstanding debt were $19.7 million and $22.6 million, respectively.

4.75% Senior Notes

On March 4, 2021, the Company issued $500.0 million aggregate principal amount of 4.75% Senior Notes. The 4.75% Senior Notes mature on March 1, 2029 and bear interest at a rate of 4.75% per annum, payable semi-annually on March 1 and September 1 of each year, commencing on September 1, 2021. The Company received proceeds of $493.9 million from issuance of the 4.75% Senior Notes, net of issuance costs of $6.1 million, which are presented in the condensed consolidated balance sheets as a reduction to the outstanding amount payable and are being amortized to interest expense using the straight-line method, which approximates the effective interest method for this debt, over the term of the 4.75% Senior Notes. A portion of the proceeds was used to repay the outstanding principal of the 5.50% Senior Notes on May 17, 2021.

The fair value of the 4.75% Senior Notes was determined based on inputs that were observable in the market, including the trading price of the 4.75% Senior Notes, when available (Level 2).

16

The Company may redeem all or part of the 4.75% Senior Notes, upon not less than a 15-day or more than a 60-day notice, however, the applicable redemption price will be determined as follows:

Redemption Period Requiring Payment of:
Redemption Up To 40% Using Cash Proceeds From An Equity Offering (3)
Make-Whole (1)
Premium (2)
Date Specific Price
4.75% Senior Notes Prior to March 1, 2024 On or after March 1, 2024 Prior to March 1, 2024 104.75%
(1) If the Company redeems the notes prior to the applicable date, the price is principal plus a make-whole premium, which means, the greater of (i) 1.0% of the principal or (ii) the excess of the present value of the redemption price at March 1, 2024 plus interest through March 1, 2024 over the principal amount.
(2) If the Company redeems the notes on or after the applicable date, the price is principal plus a premium which declines over time, as specified in the applicable indenture, together with accrued and unpaid interest.
(3) If the Company redeems the notes prior to the applicable date with net cash proceeds of one or more equity offerings, the price is equal to the amount specified above, together with accrued and unpaid interest, subject to a maximum redemption of 40% of the aggregate principal amount of the respective note being redeemed and at least 50% of the aggregate principal amount remains outstanding immediately after any such redemption (unless the notes are redeemed or repurchased substantially concurrently).

In addition, upon the occurrence of certain change of control triggering events, the Company may be required to repurchase the 4.75% Senior Notes, at a price equal to 101% of their principal amount, plus accrued and unpaid interest to the date of repurchase. The 4.75% Senior Notes contain restrictive covenants that, among other things, limit the ability of the Company and its restricted subsidiaries to incur or guarantee additional indebtedness, make certain investments and other restricted payments, transfer and sell assets, create liens, enter into transactions with affiliates, and engage in mergers, consolidations, or sales of assets.

5.50% Senior Notes

In May 2015, the Company issued $500.0 million aggregate principal amount of 5.50% Senior Notes. The 5.50% Senior Notes mature on May 31, 2023, and bear interest at a rate of 5.50% per annum, payable semi-annually on May 15 and November 15 of each year, commencing on November 15, 2015. The Company received net proceeds of $488.4 million from issuance of the 5.50% Senior Notes, net of issuance costs of $11.6 million, which are being amortized to interest expense over the term of the 5.50% Senior Notes using the straight-line method, which approximates the effective interest method for this debt. A portion of the proceeds was used to repay all then-outstanding amounts under the Company's revolving line of credit agreement with Wells Fargo Bank and the remaining proceeds were used primarily for share repurchases.

The fair value of the 5.50% Senior Notes was determined based on inputs that were observable in the market, including the trading price of the 5.50% Senior Notes when available (Level 2).

On May 17, 2021, the Company used a portion of the proceeds from the 4.75% Senior Notes to redeem the outstanding principal and accrued interest of the 5.50% Senior Notes of $493.9 million.

Term Loan Facility

In connection with the acquisition of Polycom completed on July 2, 2018, the Company entered into a Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto (the “Credit Agreement”). The Credit Agreement replaced the Company’s prior revolving credit facility in its entirety. The Credit Agreement provides for (i) a revolving credit facility with an initial maximum aggregate amount of availability of $100 million that matures in July 2023 and (ii) a $1.275 billion term loan facility priced at LIBOR plus 2.50% due in quarterly principal installments commencing on the last business day of March, June, September and December beginning with the first full fiscal quarter ending after the closing date under the Credit Agreement for the aggregate principal amount funded on the closing date under the Credit Agreement multiplied by 0.25% (subject to prepayments outlined in the Credit Agreement) and all remaining outstanding principal due at maturity in July 2025. The Company has paid the full amount of term debt principal due prior to maturity. The Company borrowed the full amount available under the term loan facility of $1.245 billion, net of approximately $30 million of discounts and issuance costs which are being amortized to interest expense over the term of the Credit Agreement using the straight-line method which approximates the effective interest method for this debt. The proceeds from the initial borrowing under the Credit Agreement were used to finance the acquisition of Polycom, to refinance certain debt of Polycom, and to pay related fees, commissions and transaction costs. The Company has additional borrowing capacity under the Credit Agreement through the revolving credit facility, which could be used to provide ongoing working capital and capital for other general corporate
17

purposes of the Company and its subsidiaries. The Company’s obligations under the Credit Agreement are currently guaranteed by Polycom and will from time to time be guaranteed by, subject to certain exceptions, any domestic subsidiaries that may become material in the future. Subject to certain exceptions, the Credit Agreement is secured by first-priority perfected lien on, and security interests in, substantially all of the personal property of the Company and each subsidiary guarantor and will from time to time also be secured by certain material real property that the Company or any subsidiary guarantor may acquire. Borrowings under the Credit Agreement bear interest due on a quarterly basis at a variable rate equal to (i) LIBOR plus a specified margin, or (ii) the base rate (which is the highest of (a) the prime rate publicly announced from time to time by Wells Fargo Bank, National Association, (b) the federal funds rate plus 0.50% or (c) the sum of 1% plus one-month LIBOR) plus a specified margin. The Company must also pay (i) an unused commitment fee ranging from 0.200% to 0.300% per annum of the average daily unused portion of the aggregate revolving credit commitments under the Credit Agreement, and (ii) a per annum fee equal to (a) for each performance standby letter of credit outstanding under the Credit Agreement with respect to non-financial contractual obligations, 50% of the applicable margin over LIBOR under the revolving credit facility in effect from time to time multiplied by the daily amount available to be drawn under such letter of credit, and (b) for each other letter of credit outstanding under the Credit Agreement, the applicable margin over LIBOR under the revolving credit facility in effect from time to time multiplied by the daily amount available to be drawn under such letter of credit.

On February 20, 2020, the Company entered into an Amendment No. 2 to Credit Agreement (the “Amendment”) by and among the Company, the financial institutions party thereto as lenders and Wells Fargo Bank, National Association, as administrative agent. The Amendment amended the Credit Agreement, as previously amended to (i) increase the maximum Secured Net Leverage Ratio (as defined in the Credit Agreement) permitted under the Credit Agreement to 3.75 to 1.00 through December 26, 2020 and 3.00 to 1.00 thereafter and (ii) decrease the minimum Interest Coverage Ratio (as defined in the Credit Agreement) required under the Credit Agreement to 2.25 to 1.00 through December 26, 2020 and 2.75 to 1.00 thereafter.

Additionally, the Amendment modified the calculation of the Secured Net Leverage Ratio and the Interest Coverage Ratio solely for purposes of compliance with Sections 7.11(a) and 7.11(b) of the Credit Agreement to (i) calculate the Secured Net Leverage Ratio net of the aggregate amount of unrestricted Cash and Cash Equivalents (as defined in the Credit Agreement) on the condensed consolidated balance sheets of the Company and its Restricted Subsidiaries (as defined in the Credit Agreement) as of the date of calculation up to an amount equal to $150,000,000 and (ii) solely for purposes of any fiscal quarter ending from December 29, 2019 through December 26, 2020, increase the cap on Expected Cost Savings (as defined in the Credit Agreement) in determining Consolidated EBITDA (as defined in the Credit Agreement) to the greater of (A) 20% of Consolidated EBITDA for such Measurement Period (as defined in the Credit Agreement) (calculated before giving effect to any such Expected Cost Savings to be added back pursuant to clause (a)(ix) of the definition of Consolidated EBITDA) and (B)(x) for the period from December 29, 2019 through March 28, 2020, $121,000,000, (y) for the period from March 29, 2020 through June 27, 2020, $107,000,000 and (z) for the period from June 28, 2020 through December 26, 2020, $88,000,000.

The financial covenants under the Credit Agreement described above are for the benefit of the revolving credit lenders only and do not apply to any other debt of the Company. The Credit Agreement also contains various other restrictions and covenants, some of which have become more stringent over time, including restrictions on our, and certain of our subsidiaries, ability to consolidate or merge, create liens, incur additional indebtedness, dispose of assets, consummate acquisitions, make investments and pay dividends and other distributions. The Company has the unilateral ability to terminate the revolving line of credit such that the financial covenants described above are no longer applicable. The Credit Agreement also contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable; provided, however, that the occurrence of an event of default as a result of a breach of a financial covenant under the Credit Agreement does not constitute a default or event of default with respect to any term facility under the Credit Agreement unless and until the required revolving lenders shall have terminated their revolving commitments and declared all amounts outstanding under the revolving credit facility to be due and payable. In addition, if the Company, any subsidiary guarantor or, with certain exceptions, any other subsidiary becomes the subject of voluntary or involuntary proceedings under any bankruptcy, insolvency or similar law, then any outstanding obligations under the Credit Agreement will automatically become immediately due and payable. Loans outstanding under the Credit Agreement will bear interest at a rate of 2.00% per annum in excess of the otherwise applicable rate (i) while a payment or bankruptcy event of default exists or (ii) upon the lenders’ request, during the continuance of any other event of default. As of July 3, 2021, the Company was in compliance with all financial covenants.
18


The Company may prepay the loans and terminate the commitments under the Credit Agreement at any time without penalty. Additionally, the Company is subject to mandatory debt repayments five business days after the filing of its consolidated financial statements for any annual period in which the Company generates Excess Cash (as defined in the Credit Agreement). In accordance with the terms of the Credit Agreement, the Company did not generate Excess Cash during Fiscal Year 2021 and therefore is not required to make any debt repayments in Fiscal Year 2022. During the three months ended July 3, 2021, the Company did not prepay any aggregate principal amount of the term loan facility. As of July 3, 2021, the Company had five letters of credit outstanding under the revolving credit facility for a total of $1.4 million. The fair value of the term loan facility was determined based on inputs that were observable in the market (Level 2).

9. RESTRUCTURING AND OTHER RELATED CHARGES

Summary of Restructuring Plans

Fiscal Year 2022 restructuring plan

During the three months ended July 3, 2021, the Company committed to actions to reduce expenses to enable strategic investments in revenue growth. The costs incurred to date under this plan include severance benefits related to headcount reductions in the Company's global workforce and facility related charges due to the closure or consolidation of offices.

Fiscal Year 2021 restructuring plan

During Fiscal Year 2021, the Company committed to additional actions to reduce expenses and align its overall cost structure to better align with projected revenue levels as well as reorganize its executive management to align to its new Chief Executive Officer's management structure. The costs incurred to date under this plan include severance benefits related to headcount reductions in the Company's global workforce and facility related charges due to the closure or consolidation of leased offices.

Legacy restructuring plans

In connection with the Polycom acquisition, in Fiscal Years 2019 and 2020 the Company initiated actions to rationalize post-acquisition operations and realign its cost structure. These actions included streamlining the global workforce, closure or consolidation of leased offices and distribution centers, consumer product portfolio optimization efforts, and legal entity rationalization.

The following table summarizes the restructuring and other related charges recognized in the Company's condensed consolidated statements of operations:
Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Severance $ 19,301  $ 22,311 
Facility (472) 1,798 
Other (1)
4,103  1,441 
Total cash charges 22,932  25,550 
Non-cash charges (2)
6,040  3,780 
Total restructuring and other related charges $ 28,972  $ 29,330 
(1) Other costs primarily represent associated legal and advisory services.
(2) Non-cash charges primarily represent accelerated depreciation due to the closure or consolidation of facilities.

19

The Company's restructuring liabilities as of July 3, 2021 is as follows:
(in thousands) As of April 3, 2021
 Accruals (1)
 Cash Payments As of July 3, 2021
FY 2022 Plan
Severance $ —  $ 20,110  $ (4,875) $ 15,235 
Facility —  —  —  — 
Other —  4,103  (3,959) 144 
Total FY 2022 Plan $ —  $ 24,213  $ (8,834) $ 15,379 
FY 2021 Plans
Severance $ 6,039  $ (801) $ (2,449) $ 2,789 
Facility 913  50  (134) 829 
Other 186  —  (150) 36 
Total FY 2021 Plans $ 7,138  $ (751) $ (2,733) $ 3,654 
Legacy Plans
Severance $ 1,222  $ (8) $ (217) $ 997 
Facility 3,281  (522) (446) 2,313 
Other —  —  —  — 
Total Legacy Plans $ 4,503  $ (530) $ (663) $ 3,310 
Severance $ 7,261  $ 19,301  $ (7,541) $ 19,021 
Facility 4,194  (472) (580) 3,142 
Other 186  4,103  (4,109) 180 
Grand Total $ 11,641  $ 22,932  $ (12,230) $ 22,343 
(1) Excludes non-cash charges of $6.0 million recorded in restructuring and other related charges on the Company's condensed consolidated statements of operations for the three months ended July 3, 2021.


10. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The components of accumulated other comprehensive income (loss), net of tax, were as follows:
(in thousands) July 3, 2021 April 3, 2021
Accumulated unrealized loss on cash flow hedges $ (3,013) $ (7,836)
Accumulated foreign currency translation adjustments 4,615  4,615 
Accumulated other comprehensive income (loss) $ 1,602  $ (3,221)

11. DERIVATIVES

Foreign Currency Derivatives

The Company's foreign currency derivatives consist primarily of foreign currency forward and option contracts. The Company does not purchase derivative financial instruments for speculative trading purposes. The derivatives expose the Company to credit risk to the extent the counterparties may be unable to meet the terms of the derivative instrument. The Company's maximum exposure to loss as a result of credit risk was equal to the carrying value of the Company's derivative assets as of July 3, 2021 and April 3, 2021. The Company seeks to mitigate such risk by limiting its counterparties to large financial institutions. In addition, the Company monitors the potential risk of loss with any one counterparty resulting from this type of credit risk on an ongoing basis.

20

The Company enters into master netting arrangements with counterparties to mitigate credit risk in derivative transactions, when possible. A master netting arrangement may allow each counterparty to net settle amounts owed between the Company and the counterparty as a result of multiple, separate derivative transactions. As of July 3, 2021, the Company had International Swaps and Derivatives Association ("ISDA") agreements with five applicable banks and financial institutions which contained netting provisions. The Company has elected to present the fair value of derivative assets and liabilities within the Company's condensed consolidated balance sheets on a gross basis even when derivative transactions are subject to master netting arrangements and may otherwise qualify for net presentation. Derivatives not subject to master netting agreements are not eligible for net presentation. As of July 3, 2021 and April 3, 2021, no cash collateral had been received or pledged related to these derivative instruments.

The Company's derivative instruments are measured using Level 2 fair value inputs. The gross fair value of the Company's outstanding derivative contracts measured on a recurring basis at the end of each period was as follows:
(in thousands) July 3, 2021 April 3, 2021
Derivative assets(1)
Non-designated hedges $ 1,218  $ 2,864 
Cash flow hedges 1,917  2,242 
Interest rate swap 2,549  — 
Total derivative assets $ 5,684  $ 5,106 
Derivative liabilities(2)
Non-designated hedges $ 19  $ 18 
Cash flow hedges 891  1,819 
Interest rate swap 8,294  9,863 
Accrued interest 102  102 
Total derivative liabilities $ 9,306  $ 11,802 
            
(1) Short-term derivative assets are recorded in other current assets and long-term derivative assets are recorded in other non-current assets on the condensed consolidated balance sheets. As of July 3, 2021, the portion of derivative assets classified as long-term was $2.7 million.

(2) Short-term derivative liabilities are recorded in accrued liabilities and long-term derivative liabilities are recorded in other non-current liabilities on the condensed consolidated balance sheets. As of July 3, 2021, the portion of derivative liabilities classified as long-term was $0.6 million.

Non-Designated Hedges

As of July 3, 2021, the Company had foreign currency forward contracts denominated in Euro ("EUR") and Great Britain Pound Sterling ("GBP"). The Company does not elect to obtain hedge accounting for these forward contracts. These forward contracts hedge against a portion of the Company’s foreign currency-denominated cash balances, accounts receivables, and accounts payables. The following table summarizes the notional value of the Company’s outstanding foreign exchange currency contracts and approximate USD equivalent at July 3, 2021:
 (in thousands) Local Currency USD Equivalent Position Maturity
EUR 36,000  $ 42,674  Sell EUR 1 month
GBP £ 9,500  $ 13,100  Sell GBP 1 month

Effect of Non-Designated Derivative Contracts on the Condensed Consolidated Statements of Operations

The effect of non-designated derivative contracts on results of operations recognized in other non-operating income, net in the condensed consolidated statements of operations was as follows:
Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Loss on foreign exchange contracts $ (486) $ (918)

21

Cash Flow Hedges

Costless Collars

The Company hedges a portion of the forecasted EUR and GBP denominated revenues with costless collars. On a monthly basis, the Company enters into option contracts with a six to twelve-month term. Collar contracts are scheduled to mature at the beginning of each fiscal quarter, at which time the instruments convert to forward contracts. The Company also enters into cash flow forwards with a three-month term. Once the hedged revenues are recognized, the forward contracts become non-designated hedges to protect the resulting foreign monetary asset position for the Company. 

The notional value of the Company's outstanding EUR and GBP option and forward contracts at the end of each period was as follows:
July 3, 2021 April 3, 2021
(in millions) EUR GBP EUR GBP
Option contracts €100.3 £20.9 €91.4 £18.1
Forward contracts €84.2 £16.1 €76.0 £15.6

The Company will reclassify all related amounts in accumulated other comprehensive income into earnings within the next twelve months.

Cross-currency Swaps

The Company hedges a portion of the forecasted Mexican Peso (“MXN”) denominated expenditures with a cross-currency swap. As of July 3, 2021, and April 3, 2021, the Company had foreign currency swap contracts of approximately MXN 369.9 million and MXN 564.3 million, respectively.

The following table summarizes the notional value of the Company's outstanding MXN currency swaps and approximate USD Equivalent at July 3, 2021:

(in thousands) Local Currency USD Equivalent Position Maturity
MXN $ 369,888  $ 17,813  Buy MXN Monthly over a twelve month period

The Company will reclassify all related amounts in accumulated other comprehensive income into earnings within the next twelve months.

Interest Rate Swap

On June 15, 2021, the Company entered into a three-year amortizing interest rate swap agreement with Bank of America, N.A. The swap has an initial notional amount of $680 million and matures on July 31, 2024. The swap involves the receipt of floating-rate interest payments for fixed interest rate payments at a rate of 0.39% over the life of the agreement. Additionally, on July 30, 2018, the Company entered into a four-year amortizing interest rate swap agreement with Bank of America, N.A. The swap has an initial notional amount of $831 million and matures on July 31, 2022. The swap involves the receipt of floating-rate interest payments for fixed interest rate payments at a rate of 2.78% over the life of the agreement.

The Company has designated the interest rate swaps as cash flow hedges. The purpose of the swaps is to hedge against changes in cash flows (interest payments) attributable to fluctuations in the Company's variable rate debt. The swaps are valued based on prevailing LIBOR rate curves on the date of measurement. The Company also evaluates counterparty credit risk when it calculates the fair value of the swaps. Changes in the fair value of the interest rate swaps are recorded to other comprehensive income and reclassified to interest expense over the life of the underlying debt as interest is accrued. During the three months ended July 3, 2021, the Company reclassified into interest expense $3.1 million and had a $5.7 million unrealized loss on its interest rate swap derivatives designated as cash flow hedges.

The Company will reclassify approximately $8.0 million in accumulated other comprehensive income into earnings within the next twelve months.
22

Effect of Designated Derivative Contracts on Accumulated Other Comprehensive Income (Loss) and Condensed Consolidated Statements of Operations

The following table presents the pre-tax effects of derivative instruments designated as cash flow hedges on accumulated other comprehensive income and the condensed consolidated statements of operations for the three months ended July 3, 2021 and June 27, 2020:
Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Loss included in accumulated other comprehensive income (loss), as of beginning of period $ (10,062) $ (20,156)
Gain (loss) recognized in other comprehensive income (loss) 440  (1,579)
Amount of (gain)/loss reclassified from accumulated other comprehensive income (loss) into net revenues 1,772  (909)
Amount of loss reclassified from accumulated other comprehensive income (loss) into cost of revenues (236) — 
Amount of gain reclassified from accumulated other comprehensive income (loss) into interest expense 3,089  3,723 
Total amount of gain reclassified from accumulated other comprehensive income (loss) to the condensed consolidated statements of operations 4,625  2,814 
Loss included in accumulated other comprehensive income (loss), as of end of period $ (4,997) $ (18,921)

12. INCOME TAXES

The Company and its subsidiaries are subject to taxation in the U.S. and in various foreign and state jurisdictions. The Company's income tax benefit is determined using an estimate of its annual effective tax rate and adjusted for discrete items that are taken into account in the relevant period. The effective tax rates for the three months ended July 3, 2021 and June 27, 2020 were 10.4% and 4.1%, respectively.

Income tax benefit was $(4.3) million and $(3.2) million for the three months ended July 3, 2021 and June 27, 2020, respectively. The provision for income taxes for the three months ended July 3, 2021 consisted primarily of federal, state, and foreign income taxes. For the three months ended July 3, 2021 and June 27, 2020, the income tax benefit differed from the U.S. federal statutory rate primarily due the valuation allowance on the U.S. federal and state deferred tax assets.

As of July 3, 2021, the Company continued to maintain a full valuation allowance against its U.S. federal and state deferred tax assets ("DTAs.") A significant portion of the Company's DTAs relate to internal intangible property restructuring between wholly-owned subsidiaries. At this time, based on evidence currently available, the Company considers it more likely than not that it will have sufficient taxable income in the future that will allow the Company to realize the DTAs; however, failure to generate sufficient future taxable income could result in some or all DTAs not being utilized in the future. If the Company is unable to generate sufficient future taxable income, a substantial valuation allowance to reduce the Company's DTAs may be required.

The Company is subject to the examination of its income tax returns by the Internal Revenue Service and other tax authorities. Significant judgment is required in evaluating our uncertain tax positions and determining the Company's provision for income taxes. During the three months ended July 3, 2021, there were no material changes to the total amount of unrecognized tax benefits. Within the next twelve months, we believe that the resolution of certain U.S. and foreign tax examinations and negotiations is reasonably possible and that a change in estimate, reducing unrecognized tax benefits, may occur. It is not possible to provide a range of the potential change until the tax examinations and negotiations progress further or the related statutes of limitations expire.

23

13. COMPUTATION OF LOSS PER COMMON SHARE

Basic loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the period. Diluted loss per share assumes the issuance of additional shares of common stock by the Company upon exercise of all outstanding stock options and vesting of restricted stock, if the effect is dilutive, in accordance with the treasury stock method. The potentially dilutive effect of outstanding stock options and restricted stock has been excluded from the computation of diluted loss per share in all periods presented, as their effect is anti-dilutive.

The following table sets forth the computation of basic and diluted loss per common share for the three months ended July 3, 2021 and June 27, 2020:
Three Months Ended
(in thousands, except per share data) July 3, 2021 June 27, 2020
Numerator:
Net loss $ (36,811) $ (75,015)
Denominator:
Weighted-average common shares outstanding 42,061  40,460 
Basic and diluted loss per common share $ (0.88) $ (1.85)
Potentially dilutive securities excluded from diluted loss per common share because their effect is anti-dilutive 405  1,546 

14. REVENUE AND MAJOR CUSTOMERS

The Company designs, builds, and markets collaboration solutions which combine legendary audio expertise and powerful video and conferencing capabilities to create endpoints that power meaningful human connections and provide solutions that make life easier when they work together and with our partner's services.

The Company’s major product categories are Headsets, Video, Voice, and Services. Headsets include wired and wireless communication headsets; Voice includes open SIP and native ecosystem desktop phones as well as conference room phones; Video includes video conferencing solutions and peripherals, such as cameras, speakers, and microphones. The broad portfolio of Services include video interoperability, hardware and support for our solutions and hardware devices, as well as professional, hosted, and managed services that are grounded in our deep expertise aimed at helping customers achieve their goals for collaboration. The Company's cloud management and analytics software enables IT administrators to configure and update firmware, monitor device usage, troubleshoot, and gain a deep understanding of user behavior. All of the Company's solutions are designed to integrate seamlessly with the platform and services of our customers choice in a wide range of Unified Communications & Collaboration ("UC&C"), Unified Communication as a Service ("UCaaS"), and Video as a Service ("VaaS") environments. The Company's RealPresence collaboration solutions range from infrastructure to endpoints and allow people to connect and collaborate globally, naturally, and seamlessly.

Product revenue is largely comprised of sales of hardware devices, peripherals, and platform software licenses used in communication and collaboration in offices and contact centers, with mobile devices, cordless phones, and computers. Services revenue primarily includes support on hardware devices, professional, hosted and managed services, and solutions to the Company's customers.

The following table disaggregates revenues by major product category for the three months ended July 3, 2021 and June 27, 2020:
24

Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Net revenues
Headsets 172,194  174,750 
   Voice 61,298  45,821 
   Video 137,711  70,887 
   Services 59,969  64,262 
Total net revenues $ 431,172  $ 355,720 

For reporting purposes, revenue is attributed to each geographic region based on the location of the customer. Other than the U.S., no country accounted for 10% or more of the Company's total net revenues for the three months ended July 3, 2021 and June 27, 2020.

The following table presents total net revenues by geography:
Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Net product revenues
U.S. $ 175,970  $ 144,289 
Europe, Middle East, and Africa 111,460  77,618 
Asia Pacific 58,270  45,431 
Americas, excluding U.S. 25,503  24,120 
Total international net product revenues 195,233  147,169 
Total net product revenues $ 371,203  $ 291,458 
Net service revenues
U.S. $ 22,758  $ 23,992 
Europe, Middle East, and Africa 14,661  16,488 
Asia Pacific 18,488  18,833 
Americas, excluding U.S. 4,062  4,949 
Total international net service revenues 37,211  40,270 
Total net service revenues $ 59,969  $ 64,262 
Total net revenues $ 431,172  $ 355,720 

Deferred revenue is primarily comprised of non-cancelable maintenance support performance obligations on hardware devices which are typically billed in advance and recognized ratably over the contract term as the services are delivered. As of July 3, 2021, the Company's deferred revenue balance was $207.6 million. As of April 3, 2021, the Company's deferred revenue balance was $213.8 million. During the three months ended July 3, 2021, the Company recognized $47.6 million in total net revenues that were recorded in deferred revenue at the beginning of the period.

The table below represents aggregate amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of July 3, 2021:
July 3, 2021
(in millions) Current Noncurrent Total
Unsatisfied (or partially unsatisfied) performance obligations $ 136.4  $ 71.2  $ 207.6 

Sales, value add, and other taxes collected concurrently with revenue producing activities are excluded from revenue.
25


The Company's indirect channel model includes both a two-tiered distribution structure, where the Company sells to distributors that subsequently sell to resellers, and a one-tiered structure where the Company sells directly to resellers. For these arrangements, transfer of control begins at the time access to the Company's services is made available to the end customer and entitlements have been contractually established, provided all other criteria for revenue recognition are met.

Commercial distributors and retailers represent the Company's largest sources of net revenues. Sales through its distribution and retail channels are made primarily under agreements allowing for rights of return and include various sales incentive programs, such as back end rebates, discounts, marketing development funds, price protection, and other sales incentives. The Company has an established sales history for these arrangements and the Company records the estimated reserves at the inception of the contract as a reflection of the reduced transaction price. Customer sales returns are estimated based on historical data, relevant current data, and the monitoring of inventory build-up in the distribution channel. Revenue reserves represent a reasonable estimation made by management and are subject to significant judgment. Estimated reserves may differ from actual returns or incentives provided, due to unforeseen customer return or claim patterns or changes in circumstances. For certain customer contracts which have historically demonstrated variability, the Company has considered the likelihood of being under-reserved and has considered a constraint accordingly. Provisions for sales returns are presented within accrued liabilities in the Company's condensed consolidated balance sheets. Provisions for promotions, rebates, and other sales incentives are presented as a reduction of accounts receivable unless there is no identifiable right offset, in which case they are presented within accrued liabilities on its condensed consolidated balance sheets. See Note 5, Details of Certain Balance Sheet Accounts, for additional details.

For certain arrangements, the Company pays commissions, bonuses and taxes associated with obtaining the contracts. The Company capitalizes such costs if they are deemed to be incremental and recoverable. The Company has elected to use the practical expedient to record the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. Determining the amortization period of costs related to obtaining a contract involves judgment. Capitalized commissions and related expenses on hardware sales and services recognized at a point in time generally have an amortization period of less than one year. Maintenance-related performance obligations generally have an amortization period greater than one year when considering renewals. Capitalized commissions are amortized to selling, general, and administrative expense on a straight-line basis. The capitalized amount of incremental and recoverable costs of obtaining contracts with a related amortization period greater than one year are was not material as of and for the three months ended July 3, 2021.

15. SEGMENT REPORTING AND GEOGRAPHIC INFORMATION

The Company's Chief Executive Officer is identified as its Chief Operating Decision Maker ("CODM"). The CODM has organized the Company, manages resource allocations and measures performance among its two operating segments: Products and Services.

The Products reportable segment includes the Company's Headsets, Voice and Video product lines. The Services reportable segment includes maintenance support on hardware devices as well as professional, managed and cloud services and solutions.

In managing the two operating segments the CODM uses information about their revenue and gross margin after adjustments to exclude certain non-cash transactions and activities that are not reflective of the Company's ongoing or core operations as further described below. The CODM does not review asset information by segment.

Purchase accounting amortization: Represents the amortization of purchased intangible assets recorded in connection with the acquisition of Polycom.

Deferred revenue purchase accounting: Represents the impact of fair value purchase accounting adjustments related to deferred revenue recorded in connection with the Acquisition of Polycom. The Company's deferred revenue primarily relates to service revenue associated with non-cancelable maintenance support on hardware devices which are typically billed in advance and recognized ratably over the contract term as those services are delivered. This adjustment represents the amount of additional revenue that would have been recognized during the period absent the write-down to fair value required under purchase accounting guidelines.

Stock compensation expense: Represents the non-cash expense associated with the Company's issuance of common stock and stock-based awards to employees and non-employee directors.
26

The following table presents segments results for revenue and gross margin, as reviewed by the CODM, and their reconciliation to the Company's condensed consolidated GAAP results:
Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Segment revenues, as reviewed by CODM
Products $ 371,379  $ 291,786 
Services 61,053  69,016 
Total segment revenues, as reviewed by CODM $ 432,432  $ 360,802 
Segment gross profit, as reviewed by CODM
Products $ 153,548  $ 134,242 
Services 40,266  46,243 
Total segment gross profit, as reviewed by CODM $ 193,814  $ 180,485 

Three Months Ended
(in thousands) July 3, 2021 June 27, 2020
Total segment revenues, as reviewed by CODM $ 432,432  $ 360,802 
Deferred revenue purchase accounting (1,260) (5,082)
GAAP net revenues $ 431,172  $ 355,720 
Total segment gross profit, as reviewed by CODM (1)
$ 193,814  $ 180,485 
Purchase accounting amortization (16,238) (18,238)
Deferred revenue purchase accounting (1,260) (5,082)
Stock-based compensation (1,127) (833)
GAAP gross profit $ 175,189  $ 156,332 
(1) Includes depreciation expense of $3.6 million and $3.3 million for the three months ended July 3, 2021 and June 27, 2020, respectively. 


27

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

CERTAIN FORWARD-LOOKING INFORMATION

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements relating to our intentions, beliefs, projections, outlook, analyses or current expectations that are subject to many risks and uncertainties. Such forward-looking statements and the associated risks and uncertainties include, but are not limited to: (i) our beliefs with respect to the length and severity of the COVID-19 (coronavirus) outbreak, and its impact across our businesses, our operations and global supply chain, including (a) our expectations that the virus has caused, and will continue to cause, a shift to a hybrid work environment and that the elevated demand we have experienced in certain product lines, including our Enterprise Headsets and Video devices, will continue over the long term, (b) our belief that we will continue to experience increased customer and partner demand in collaboration endpoints, and that we will be able to design new product offerings to meet the change in demand due to a global hybrid work environment, (c) our expectations related to our Voice product lines, as well as our services attachment rate for such products, which have been, and may continue to be, negatively impacted as companies have delayed returning their workforces to offices in many countries due to the continued impact of COVID-19; and (d) the impact of the virus on our distribution partners, resellers, end-user customers and our production facilities, including our ability to obtain alternative sources of supply if our production facility or other suppliers are impacted by future shutdowns; (ii) our expectations related to global supply chain disruptions, including our belief that shortages of key components, including semiconductor chips, have impacted companies worldwide both within and outside of our industry, and that we will continue to experience a shortage of adequate component supply, including integrated circuits and manufacturing capacity, long lead times for raw materials and components, increased costs, increased purchase commitments and a delay in our ability to fulfill orders, which has had, and may continue to have, an adverse impact on our business and operating results; (iii) expectations related to our ability to fulfill the backlog generated by supply constraints and to timely supply the number of products to fulfill current and future customer demand; (iv) risks associated with our dependence on manufacturing operations conducted in our own facility in Tijuana, Mexico and through contract manufacturers, original design manufacturers, and suppliers to manufacture our products, to timely obtain sufficient quantities of materials, as well as finished products of acceptable quality, at acceptable prices, and in the quantities necessary for us to meet critical schedules for the delivery of our own products and services and fulfill our anticipated customer demand; (v) risks associated with our ability to secure critical components from sole source suppliers or identify alternative suppliers and/or buy component parts on the open market or completed goods in quantities sufficient to meet our requirements on a timely basis, affecting our ability to deliver products and services to our customers; (vi) our belief that consolidations of suppliers has occurred, and may continue to occur, which may negatively impact our ability to access certain parts and may result in higher prices which will impact our gross margins; (vii) risks related to increased cost of goods sold, including increased freight and other costs associated with expediting shipment and delivery of high-demand products to key markets in order to meet customer demand; (viii) continued uncertainty and potential impact on future quarters if sourcing constraints continue and/or price volatility occurs, which could continue to negatively affect our profitability and/or market share; (ix) the impact if global or regional economic conditions deteriorate further, on our customers and/or partners, including increased demand for pricing accommodations, delayed payments, delayed deployment plans, insolvency or other issues which may increase credit losses; (x) risks related to restrictions or delays in global return to worksites as a result of COVID-19, which continues to impact our employees and our customers worldwide, which has negatively impacted our voice product lines, and restricted customer engagement; (xi) expectations related to our ability to supply products in a timely manner to satisfy perishable demand; (xii) expectations related to our customers’ purchasing decisions and our ability to pivot quickly enough and/or match product production to demand, particularly given long lead times and the difficulty of forecasting unit volumes and acquiring the component parts and materials to meet demand without having excess inventory or incurring cancellation charges; (xiii) risks associated with significant and/or abrupt changes in product demand which increases the complexity of management’s evaluation of potential excess or obsolete inventory; (xiv) risks associated with the bankruptcy or financial weakness of distributors or key customers, or the bankruptcy of or reduction in capacity of our key suppliers; (xv) expectations related to our Services segment revenues, particularly as we introduce new generation, less complex, product solutions, or as companies shift from on premises to work from home options for their workforce, which have resulted and may continue to result in decreased demand for our professional, installation and/or managed service offerings; (xvii) expectations that our current cash on hand, additional cash generated from operations, together with sources of cash through our credit facility, either alone or in combination with our election to suspend our dividend payments, will meet our liquidity needs; (xviii) expectations relating to our ability to generate sufficient cash flow from operations to meet our debt covenants, and timely repay all principal and interest amounts drawn under our credit facility as they become due; (xix) risks associated with our channel partners’ sales reporting, product inventories and product sell through since we sell a significant amount of products to channel partners who maintain their own inventory of our products; (xx) expectations related to our efforts to drive sales and sustainable profitable revenue growth, to improve our profitability and cash flow, and accelerate debt reduction and de-levering; (xxi) our expectations regarding growth objectives related to our strategic initiatives designed to expand our
28

Table of Contents
product and service offerings, including our expectations related to building strategic alliances and key partnerships with providers of collaboration tools and platforms to drive revenue growth and market share, our expectations for new products launches, the timing of their releases and their expected impact on future growth and on our existing products, and our belief that our product management and personal device services, including Poly Lens and/or Poly+, will drive growth and profitability for both us and our partners through the sale of our product, services and solutions; (xxii) risks associated with forecasting sales and procurement demands, which are inherently difficult, particularly with continuing uncertainty in regional and global economic conditions; (xxv) our expectations regarding our ability to control costs, streamline operations and successfully implement our various cost-reduction activities and realize anticipated cost savings under such cost-reduction initiatives; (xxvi) expectations relating to our earnings guidance, particularly as economic uncertainty, including, without limitation, uncertainty related to the continued impact of COVID-19, the current constraints in our ability to source key components for our products, continued uncertainty in the macro-economic climate and other external factors, puts further pressure on management judgments used to develop forward-looking financial guidance and other prospective financial information; (xxvii) expectations related to GAAP and non-GAAP financial results for the second quarter and full Fiscal Year 2022, including net revenues, adjusted EBITDA, tax rates, intangibles amortization, diluted weighted average shares outstanding and diluted EPS; (xxviii) our beliefs regarding the UC&C market, market dynamics and opportunities, and customer and partner behavior as well as our position in the market, including risks associated with the potential failure of our UC&C solutions to be adopted with the breadth and speed we anticipate; (xxix) uncertainties attributable to currency fluctuations, including fluctuations in foreign exchange rates and/or new or greater tariffs on our products; (xxx) our belief that the increased adoption of certain technologies and our open architecture approach has and will continue to increase demand for our solutions; (xxxi) expectations related to the micro and macro-economic conditions in our domestic and international markets and their impact on our future business; (xxxii) our forecast and estimates with respect to tax matters, including expectations with respect to utilizing our deferred tax assets; and (xxxiii) our expectations regarding pending and potential future litigation, in addition to other matters discussed in this Annual Report on Form 10-K that are not purely historical data. Such forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties that may cause actual results to differ materially from the forward-looking statements. Factors that could cause actual results and events to differ materially from such forward-looking statements are included, but not limited to, those discussed in this Quarterly Report on Form 10-Q; in Part I, "Item 1A. Risk Factors" of our Annual Report on Form 10-K for the fiscal year ended April 3, 2021, filed with the Securities and Exchange Commission ("SEC") on May 18, 2021; and other documents we have filed with the SEC. We undertake no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.
OVERVIEW

Plantronics, Inc. (“Poly,” “Company,” “we,” “our,” or “us”) is a leading global communications technology company that designs, manufactures, and markets integrated communications and collaboration solutions for professionals. We offer premium audio and video products designed to work in an era where work is no longer a place and enterprise work forces are increasingly distributed. Our products and services are designed and engineered to connect people with high fidelity and incredible clarity. They are professional-grade, easy to use, and work seamlessly with major video- and audio-conferencing platforms.

Our major product categories are Headsets, Video, Voice, and Services. Headsets include wired and wireless communication headsets; Voice includes open Session Initiation Protocol ("SIP") and native ecosystem desktop phones, as well as conference room phones; Video includes conferencing solutions and peripherals, such as cameras, speakers, and microphones. All of our solutions are designed to integrate seamlessly with the platform and services of our customers’ choice in a wide range of Unified Communications & Collaboration (“UC&C”), Unified Communication as a Service (“UCaaS”), and Video as a Service (“VaaS”) environments.

Additionally, our cloud management and analytics software enables Information Technology ("IT") administrators to configure and update firmware, monitor device usage, troubleshoot, and gain a deep understanding of user behavior. We offer a broad portfolio of services including video interoperability, support for our solutions and hardware devices, as well as professional, hosted, and managed services that are grounded in our deep expertise aimed at helping our customers achieve their goals for collaboration.

We sell our products through a well-developed global network of distributors and channel partners, including value-added resellers, integrators, direct marketing resellers, and service providers, as well as through both traditional and online retailers, office supply distributors, and e-commerce channels. We have well-established distribution channels in the Americas, Europe, Middle East, Africa, and Asia Pacific, where use of our products is widespread.

29

Table of Contents
Our fiscal year ends on the Saturday closest to the last day of March. The year ended April 2, 2022 ("Fiscal Year 2022") has 52 weeks, while the year ended April 3, 2021 ("Fiscal Year 2021") had 53 weeks. The three months ended July 3, 2021 ("first quarter Fiscal Year 2022") and June 27, 2020 ("first quarter Fiscal Year 2021") each had 13 weeks.

Impact of the Current Environment and COVID-19 on Our Business

COVID-19 has continued to spread globally and continues to add uncertainty and influence global economic activity, the global supply chain, and financial markets. The impact of the pandemic on our operations has varied by local conditions, government mandates, and business limitations, including travel bans, remote work, and other restrictions.
Shelter-in-place mandates led to a massive increase in remote work. As a result, during Fiscal Year 2021 we experienced elevated demand for certain enterprise Headsets and Video devices and a decline in demand for our Voice products and associated Services, as companies continued to shift from in-office to work-from-home arrangements for many of their office workers. The acceleration in customer and partner demand for these products to support remote work environments, remote learning, and telemedicine opportunities led to increased sales and operating income. During the fourth quarter of Fiscal Year 2021 and continuing in the first quarter of Fiscal Year 2022, we experienced elevated demand for certain Video and Voice devices as companies began to shift from work-from-home arrangements to hybrid work models.
However, the impact of COVID-19 is fluid and uncertain, and it has caused, and may continue to cause, various negative effects as we continue to experience periodic constraints in our supply chain, specifically the sourcing of certain components and raw materials, and increased logistics costs and suffer other adverse effects on our gross margins to meet customer demand for specific Headsets and Video products. As a result, the impact of COVID-19 to date has had mixed effects on our results of operations and we expect supply chain constraints to limit our ability to meet demand in the short-term.
We have experienced and continue to monitor limited supply and longer lead times for certain key components, such as semiconductor chips, necessary to complete production and meet customer demand, including fulfillment of our backlog. In particular, we are experiencing long lead times for global semiconductor chips and other key components. We do not manufacture these component parts and currently purchase certain parts, including semiconductor chips and sub-assemblies that require semiconductor chips, from single or limited sources. Additionally, constrained supply has resulted in increased prices for certain components, including semiconductor chips, on the spot market, increased transportation costs, inefficiencies at our owned manufacturing facility in Tijuana, Mexico, and inability to fulfill backlog for certain products timely. We continue to monitor our supply chain and are taking action against limited supply and increasing lead times, including increased spot market purchases, outreach to critical suppliers, and entering into contractual obligations to secure supply. These factors, among others, are affecting and are expected to continue to affect total net revenue and gross margin rates. We are unable to estimate the extent and the period over which these conditions will exist.
In responding to this pandemic, employee safety continues to be a critical concern for Poly and we have taken measures to protect our employees globally by adherence to public safety and shelter in place directives, physical distancing protocols within offices and manufacturing facilities, providing personal protective equipment, including face masks and hand sanitizers, conducting routine sanitation of facilities, requiring health monitoring before entry into Poly facilities and restricting the number of visitors to our sites. The safety protocols implemented globally meet or exceed current regulations, however we continue to monitor employees’ safety and evolving regulatory requirements. Although our manufacturing facility remains open and certain office employees may utilize our offices when necessary, the majority of all non-factory employees continue to work from home, using headsets and other Poly-issued equipment. We provided COVID-19 vaccines to our employees and their immediate families, as well as other workers, at our manufacturing facility on a voluntary basis free of charge.
The full extent and duration of the impact of the COVID-19 pandemic on our business continues to be uncertain and difficult to predict and will depend on many factors outside of our control, including the extent and duration of the pandemic, mutations, and variants of the virus, the development and availability of effective treatments, including the availability of vaccines for our global workforce, mandates of protective public safety measures, and the impact of the pandemic on the global economy, global supply chains, and demand for our products. It is not possible at this time to foresee whether the outbreak of COVID-19 or other events beyond our control will be effectively contained, nor can we estimate the entirety of the impact that COVID-19 or such other pandemics or natural or man-made disaster will have on the global economy, our business, customers, suppliers, or other business partners. As such, impacts from such events on Poly are highly uncertain and we will continue to assess the impact from such events on our condensed consolidated financial statements.

30

Table of Contents
First Quarter Fiscal Year 2022 Highlights

Total net revenues for the first quarter of Fiscal Year 2022 were $431.2 million, an increase of $75.5 million or 21.2%, compared to the first quarter of Fiscal Year 2021, primarily driven by increased sales in our Video and Voice product categories.

Product gross margin rate for the first quarter of Fiscal Year 2022 decreased from 39.4% in the first quarter of Fiscal Year 2021 to 36.6%, primarily driven by increased component, transportation, and manufacturing costs, as well as unfavorable product mix.

We redeemed the outstanding principal and accrued interest on the 5.50% Senior Notes of $493.9 million during the first quarter of Fiscal Year 2022. On June 15, 2021, we entered into a three-year amortizing interest rate swap agreement as part of our overall strategy to manage our exposure to market risks associated with fluctuations in interest rates on our $1.275 billion term loan facility.

During the first quarter of Fiscal Year 2022, we announced the Voyager Focus 2 headset, a next generation USB and Bluetooth headset, designed with Poly's next generation Acoustic Fence Technology and Advanced Digital Hybrid Active Noise Cancellation. This product was available during the first quarter of Fiscal Year 2022 and did not have a material impact on total net revenues.

RESULTS OF OPERATIONS

The Company’s reportable segments are Products and Services. Our Products reportable segment includes the Headsets, Voice, and Video product lines. Our Services reportable segment includes maintenance support on hardware devices as well as, professional, managed and cloud services and solutions.

Total Net Revenues

The following table sets forth total net revenues by reportable segment for the first quarter of Fiscal Years 2022 and 2021:

Three Months Ended
(in thousands, except percentages) July 3, 2021 June 27, 2020 Change
Products $ 371,203  $ 291,458  $ 79,745  27.4  %
Services 59,969  64,262  (4,293) (6.7) %
Total net revenues $ 431,172  $ 355,720  $ 75,452  21.2  %

Products

Total product net revenues increased in the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to the following:

Video product category net revenues increased, driven by the shift to hybrid work arrangements and the need for office workers to be able to effectively communicate and collaborate regardless of location, as well as remote learning, telemedicine, and the continued ramp of our new video portfolio.
Voice product category net revenues also increased as companies returned or made plans to return to the office.

Services

Total services net revenues decreased in the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to the Video product mix shift from legacy Platform and Telepresence to recently launched Studio video bars, which are less complex, easier to install and operate, and carry optional service contracts. The decrease was partially offset by the impact of the deferred revenue fair value adjustment resulting from the Polycom acquisition.

31

Table of Contents
Geographic Region

The following table sets forth total net revenues by geographic region for the first quarter of Fiscal Years 2022 and 2021:

Three Months Ended
(in thousands, except percentages) July 3, 2021 June 27, 2020 Change
United States $ 198,728  $ 168,281  $ 30,447  18.1  %
International net revenues:
Europe, Middle East, and Africa 126,121  94,106  32,015  34.0  %
Asia Pacific 76,758  64,264  12,494  19.4  %
Americas, excluding United States 29,565  29,069  496  1.7  %
Total international net revenues 232,444  187,439  45,005  24.0  %
Total net revenues $ 431,172  $ 355,720  $ 75,452  21.2  %

United States (U.S.)

U.S. total net revenues increased in the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to increased net sales in the Video and Voice product categories, partially offset by decreased net sales in Headsets. U.S. Services total net revenues were materially unchanged during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021.

International

International total net revenues increased in the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to increased sales in the Video, Headset, and Voice product categories, partially offset by decreased net sales in Services.

During the first quarter of Fiscal Year 2022, changes in foreign exchange rates favorably impacted total net revenues by $9.6 million, net of the effects of hedging, compared to a $2.5 million unfavorable impact on revenue in the first quarter of fiscal year 2021.



32

Table of Contents
Cost of Revenues and Gross Profit

Cost of revenues consists primarily of direct and contract manufacturing costs, amortization of acquired technology, freight, warranty, charges for excess and obsolete inventory, depreciation, duties, royalties, and overhead expenses. 
  Three Months Ended
(in thousands, except percentages) July 3, 2021 June 27, 2020 Change
Products:
Net revenues $ 371,203 $ 291,458 $ 79,745  27.4  %
Cost of revenues 235,196 176,615 58,581  33.2  %
Gross profit $ 136,007 $ 114,843 $ 21,164  18.4  %
Gross profit % 36.6  % 39.4  %
Services:
Net revenues $ 59,969 $ 64,262 $ (4,293) (6.7) %
Cost of revenues 20,787 22,773 (1,986) (8.7) %
Gross profit $ 39,182 $ 41,489 $ (2,307) (5.6) %
Gross profit % 65.3  % 64.6  %
Total:
Net revenues $ 431,172 $ 355,720 $ 75,452  21.2  %
Cost of revenues 255,983 199,388 56,595  28.4  %
Gross profit $ 175,189 $ 156,332 $ 18,857  12.1  %
Gross profit % 40.6  % 43.9  %

Products

Gross profit as a percentage of total product net revenues decreased in the first quarter of Fiscal Year 2022 as compared to the first quarter of Fiscal Year 2021, primarily driven by increased component, transportation, and manufacturing costs, as well as unfavorable product mix. The increase in component costs was primarily driven by increased spot market purchases of certain key components, such as semiconductor chips, due to global supply shortages. Transportation costs increased as a result of high global demand and limited capacity of air freight carriers and increased air freight usage to mitigate longer component lead times to meet our commitments to customers. Additionally, the supply shortages and increased lead times resulted in inefficiencies at our manufacturing facility. These declines were partially offset by the non-recurrence of a one-time provision for inventory excess and obsolescence recorded during the first quarter of Fiscal Year 2021.

Services

Compared to the first quarter of Fiscal Year 2021, gross profit as a percentage of total services net revenues increased in the first quarter of Fiscal Year 2022, primarily due to the decrease in the acquisition-related deferred revenue fair value adjustment.






33

Table of Contents
Operating Expenses

Operating expenses for the first quarter of Fiscal Years 2022 and 2021 were as follows:
  Three Months Ended
(in thousands, except percentages) July 3, 2021 June 27, 2020 Change
Research, development, and engineering $ 45,466 $ 50,029 $ (4,563) (9.1) %
% of total net revenues 10.5  % 14.1  %
Selling, general and administrative 120,734 116,644 4,090  3.5  %
% of total net revenues 28.0  % 32.8  %
Loss, net from litigation settlements —  17,561 (17,561) 100.0  %
% of total net revenues —  % 4.9  %
Restructuring and other related charges 28,972 29,330 (358) (1.2) %
% of total net revenues 6.7  % 8.2  %
Total Operating Expenses $ 195,172 $ 213,564 $ (18,392) (8.6) %
% of total net revenues 45.3  % 60.0  %

Research, Development, and Engineering

Research, development, and engineering costs are expensed as incurred and consist primarily of compensation costs, outside services, expensed materials, and overhead expenses.

Research, development, and engineering expenses decreased during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to lower compensation expense due to reduction in headcount, cost control efforts, lower incentive compensation, and decreased travel expenses due to COVID-19 restrictions.

Selling, General, and Administrative

Selling, general, and administrative costs are expensed as incurred and consist primarily of compensation costs, marketing costs, travel expenses, professional service fees, and overhead expenses.

Selling, general and administrative expenses increased during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to higher sales commissions due to increased sales and higher advertising and promotional activity. The increases were partially offset by lower compensation expense due to reduced headcount, decreased travel expenses due to COVID-19 restrictions, and other cost control efforts.

Loss, net from Litigation Settlements

Loss, net from litigation settlements decreased during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021 due to the recording of one-time litigation charges for settlements during the prior period.

Restructuring and Other Related Charges

Restructuring and other related charges was materially unchanged during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021. During the first quarter of Fiscal Years 2022 and 2021 we recorded restructuring and other related charges to reduce expenses and optimize our cost structure. These actions consisted of headcount reductions and office closures.

34

Table of Contents
Interest Expense

Interest expense for the first quarter of Fiscal Years 2022 and 2021 was as follows:
  Three Months Ended
(in thousands, except percentages) July 3, 2021 June 27, 2020 Change
Interest expense $ 21,782 $ 21,184 $ 598  (2.8) %
% of total net revenues 5.1  % 6.0  %

Interest expense increased during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021, primarily due to amortization of the remaining debt issuance costs related to the 2023 Senior Notes, which were redeemed during the first quarter of Fiscal Year 2022, and interest expense related to the 2029 Senior Notes which were issued in the fourth quarter of Fiscal Year 2021, partially offset by lower interest expense related to the 2023 Senior Notes and lower outstanding principal balance on the term loan facility.

Other Non-Operating Income, Net

Other non-operating income, net for the first quarter of Fiscal Years 2022 and 2021 was as follows:
  Three Months Ended
(in thousands, except percentages) July 3, 2021 June 27, 2020 Change
Other non-operating income, net $ (692) $ (224) $ (468) 208.9  %
% of total net revenues (0.2) % (0.1) %

Other non-operating income, net increased during the first quarter of Fiscal Year 2022 compared to the first quarter of Fiscal Year 2021 primarily due to lower losses on non-designated foreign currency forward derivatives.

Income Tax Benefit
  Three Months Ended
(in thousands except percentages) July 3, 2021 June 27, 2020 Change
Income (loss) before income taxes $ (41,073) $ (78,192) $ 37,119  47.5  %
Income tax benefit (4,262) (3,177) (1,085) (34.2) %
Net income (loss) $ (36,811) $ (75,015) $ 38,204  50.9  %
Effective tax rate 10.4  % 4.1  %

The Company and its subsidiaries are subject to taxation in the U.S. and in various foreign and state jurisdictions. The Company's income tax benefit is determined using an estimate of its annual effective tax rate and adjusted for discrete items that are taken into account in the relevant period. The effective tax rates for the first quarter of Fiscal Years 2022 and 2021 were 10.4% and 4.1%, respectively.

Income tax benefit was $(4.3) million and $(3.2) million for the first quarter of Fiscal Years 2022 and 2021, respectively. The provision for income taxes for the three months ended July 3, 2021 consisted primarily of federal, state, and foreign income taxes. For the first quarter of Fiscal Year 2022, the income tax benefit differed from the U.S. federal statutory rate primarily due the valuation allowance on the U.S. federal and state deferred tax assets that continues to be maintained as of July 3, 2021.

A significant portion of the Company's deferred tax assets ("DTAs") relate to internal intangible property restructuring between wholly-owned subsidiaries. At this time, based on evidence currently available, the Company considers it more likely than not that it will have sufficient taxable income in the future that will allow the Company to realize the DTAs; however, failure to generate sufficient future taxable income could result in some or all DTAs not being utilized in the future. If the Company is unable to generate sufficient future taxable income, a substantial valuation allowance to reduce the Company's DTAs may be required.

35

Table of Contents
FINANCIAL CONDITION

Liquidity and Capital Resources

The following tables present selected financial information and statistics as of July 3, 2021 and April 3, 2021 and for the first quarter of Fiscal Years 2022 and 2021 (in thousands):
July 3, 2021 April 3, 2021
Cash, cash equivalents, and short-term investments $ 212,714  $ 217,119 
Property, plant, and equipment, net 131,294  140,875 
Current portion of long-term debt —  478,807 
Long-term debt, net 1,497,119  1,496,064 
Working capital 207,890  213,975 
Three Months Ended
July 3, 2021 June 27, 2020
Cash provided by operating activities $ 849  $ 41,722 
Cash used in investing activities (10,456) (3,645)
Cash used in financing activities (490,905) (2,734)

Our cash and cash equivalents as of July 3, 2021 consisted of bank deposits with third-party financial institutions. As of July 3, 2021, of our $212.7 million of cash, cash equivalents, and short-term investments, $105.5 million was held domestically while $107.2 million was held by foreign subsidiaries, and approximately 70% was based in USD-denominated instruments. As of July 3, 2021, our short-term investments were composed of mutual funds. An additional source of liquidity is $98.6 million of availability from our revolving credit facility, net of outstanding letters of credit.

Historically, we use cash provided by operating activities as our primary source of liquidity. We expect that cash provided by operating activities will fluctuate in future periods, including the current quarter as a result of a number of factors, including fluctuations in our revenues, the timing of compensation-related payments, such as our annual bonus/variable compensation plan, interest payments on our long-term debt, product shipments, accounts receivable collections, inventory and supply chain management, and the timing and amount of tax and other payments. 

During the first quarter of Fiscal Year 2022, cash provided by operating activities of $0.8 million was a result of non-cash adjustments to net loss of $66.3 million, partially offset by $(36.8) million of net loss and a decrease in the net change in operating assets and liabilities of $(28.7) million. Cash used in investing activities of ($10.4) million consisted primarily of capital expenditures of ($6.1) million and other investing activities of ($4.0) million. Cash used in financing activities consisted primarily of ($480.7) million of repayments of long-term debt and $($10.2) million of employees' tax withheld and paid for restricted stock and restricted stock units.

Capital Expenditures

We anticipate our capital expenditures in Fiscal Year 2022 will be approximately $35 million to $45 million, relating primarily to costs associated in our manufacturing capabilities, including tooling for new products, new information technology investments, and facilities upgrades. We will continue to evaluate new business opportunities and new markets. As a result, our future growth within the existing business or new opportunities and markets may dictate the need for additional facilities and capital expenditures to support that growth.

Debt

In July 2018, in connection with the Polycom acquisition, the Company entered into a Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, and the lenders party thereto and borrowed the full amount available under the term loan facility of $1.245 billion, net of approximately $30 million of discounts and issuance costs. During the first quarter of Fiscal Year 2022, we did not repurchase any of our outstanding principal. As of July 3, 2021, we had $1.0 billion of principal outstanding.

36

Table of Contents
On February 20, 2020, the Company entered into an Amendment in order to relax certain financial covenants on the revolving line of credit. The financial covenants under the Credit Agreement are for the benefit of the revolving credit lenders only and do not apply to any other debt of the Company. As of July 3, 2021, the Company has five outstanding letters of credit on the revolving credit facility for a total of $1.4 million and had $98.6 million available under the revolving line of credit. As of July 3, 2021, the Company was in compliance with the financial covenants.

On July 30, 2018, the Company entered into a 4-year amortizing interest rate swap agreement with Bank of America, N.A. The swap has an initial notional amount of $831 million and matures on July 31, 2022. On June 15, 2021, the Company entered into a three-year amortizing interest rate swap agreement with Bank of America, N.A. The swap has an initial notional amount of $680 million and matures on July 31, 2024. During the three months ended July 3, 2021, the Company reclassified into interest expense $3.1 million and recorded a $5.7 million unrealized loss on its interest rate swap derivative designated as a cash flow hedge.

On March 4, 2021, the Company issued $500.0 million aggregate principal amount of 4.75% Senior Notes. The 4.75% Senior Notes mature on March 1, 2029 and bear interest at a rate of 4.75% per annum, payable semi-annually on March 1 and September 1 of each year, commencing on September 1, 2021. A portion of the proceeds from the 4.75% Senior Notes was used to redeem the outstanding principal and accrued interest on the 5.50% Senior Notes of $493.9 million. As of July 3, 2021, $500 million of principal was outstanding.

During the first quarter of Fiscal Year 2022, we redeemed the outstanding principal and accrued interest on the 5.50% Senior Notes of $493.9 million.

We may at any time and from time to time, depending on market conditions and prices, continue to retire or purchase our outstanding debt through cash purchases and/or exchanges for equity or debt, in open-market purchases, privately negotiated transactions, or otherwise. Such repurchases or exchanges, if any, will be upon such terms and at such prices as we may determine, and will depend on prevailing market conditions, our liquidity requirements, contractual restrictions and other factors. In addition, our liquidity, capital resources, and results of operations in any period could be affected by repurchases of our common stock, the payment in the future of cash dividends if the Board determines to reinstate the dividend program, the exercise of outstanding stock options, restricted stock grants under stock plans, and the issuance of common stock under the ESPP. The acquisition of Polycom affected our liquidity and leverage ratios and we are working to reduce our debt leverage ratios by prioritizing the repayment of the debt obtained to finance such acquisition. We receive cash from the exercise of outstanding stock options under our stock plan and the issuance of shares under our ESPP. However, the resulting increase in the number of outstanding shares from these equity grants and issuances could affect our earnings per share. We cannot predict the timing or amount of proceeds from the sale or exercise of these securities or whether they will be exercised, forfeited, canceled, or will expire.

Further information regarding the Company’s debt issuances and related hedging activity can be found in Note 8, Debt, and Note 11, Derivatives, of the accompanying notes to the condensed consolidated financial statements within “Part I. Item 1. Financial Statements” of this Quarterly Report on Form 10-Q.

Common Stock Repurchases

From time to time, our Board authorizes programs under which we may repurchase shares of our common stock in the open market or through privately negotiated transactions, including accelerated stock repurchase agreements. On November 28, 2018, the Board approved a 1 million share repurchase program expanding our capacity to repurchase shares to approximately 1.7 million shares. During the first quarter of Fiscal Year 2022, we did not repurchase any shares of our common stock. As of July 3, 2021, there remained 1,369,014 shares authorized for repurchase under the existing stock repurchase program.

We believe that our current cash and cash equivalents, short-term investments, cash provided by operations, and availability of additional funds under the Credit Agreement, as amended from time to time, will be sufficient to fund our operations for one year from the date of issuance of these financial statements. However, any projections of future financial needs and sources of working capital are subject to uncertainty on our financial results. Readers are cautioned to review the risks, uncertainties, and assumptions set forth in this Quarterly Report on Form 10-Q, including the section entitled "Certain Forward-Looking Information" and the risk factors set forth in our Annual Report on Form 10-K for the fiscal year ended April 3, 2021, filed with the SEC on May 18, 2021, and other periodic filings with the SEC, any of which could affect our estimates for future financial needs and sources of working capital.

37

Table of Contents
OFF BALANCE SHEET ARRANGEMENTS AND CONTRACTUAL OBLIGATIONS

We have not entered into any transactions with unconsolidated entities whereby we have financial guarantees, subordinated retained interests, derivative instruments, or other contingent arrangements that expose us to material continuing risks, contingent liabilities, or any other obligation under a variable interest in an unconsolidated entity that provides us with financing and liquidity support, market risk, or credit risk support.

Consigned Inventory

A substantial portion of the raw materials, components, and subassemblies used in our products are provided by our suppliers on a consignment basis. These consigned inventories are not recorded on our condensed consolidated balance sheets until we take title to the raw materials, components, and subassemblies, which occurs when they are consumed in the production process. Prior to consumption in the production process, our suppliers bear the risk of loss and retain title to the consigned inventory. The agreements allow us to return parts in excess of maximum order quantities to the suppliers at the supplier’s expense. Returns for other reasons are negotiated with the suppliers on a case-by-case basis and to date have been immaterial. If our suppliers were to discontinue financing consigned inventory, it would require us to make cash outlays and we could incur expenses which, if material, could negatively affect our business and financial results. As of July 3, 2021 and April 3, 2021, we had off-balance sheet consigned inventories of $53.6 million and $57.3 million, respectively.

Unconditional Purchase Obligations

We use several contract manufacturers to manufacture raw materials, components, and subassemblies for our products through our supply and demand information that typically covers periods up to 52 weeks. The contract manufacturers use this information to acquire components and build products. We also obtain individual components for our products from a wide variety of individual suppliers using a combination of purchase orders, supplier contracts, including annual minimum purchase obligations, and open orders based on projected demand information. As of July 3, 2021, we had outstanding off-balance sheet third-party manufacturing, component purchase, and other general and administrative commitments of $599.5 million, including the off-balance sheet consigned inventories of $53.6 million. We expect to consume unconditional purchase obligations in the normal course of business, net of an immaterial purchase commitments reserve. In certain instances, these agreements allow us the option to cancel, reschedule, and adjust our requirements based on our business needs in partnering with our suppliers given the current environment.

Except as described above, there have been no material changes in our contractual obligations as described in our Annual Report on Form 10-K for the fiscal year ended April 3, 2021.

CRITICAL ACCOUNTING ESTIMATES

For a complete description of what we believe to be the critical accounting estimates used in the preparation of our condensed consolidated financial statements, refer to our Annual Report on Form 10-K for the fiscal year ended April 3, 2021. There have been no material changes to our critical accounting estimates during the first quarter of Fiscal Year 2022.

Recent Accounting Pronouncements

Recent accounting pronouncements issued by the Financial Accounting Standards Board ("FASB") did not and are not expected to have a material impact on the Company's financial position, results of operations, or cash flows.
38

Table of Contents
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The discussion of our exposure to market risk related to changes in interest rates and foreign currency exchange rates contains forward-looking statements that are subject to risks and uncertainties.  Actual results could vary materially as a result of a number of factors, including those discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended April 3, 2021, which could materially affect our business, financial position, or future results of operations.

INTEREST RATE RISK

Our exposure to market risk for changes in interest rates relates primarily to our floating-rate interest payments under our $1.275 billion term loan facility. Borrowings under the Credit Agreement bear interest at a variable rate equal to (i) LIBOR plus a specified margin, or (ii) the base rate (which is the highest of (a) the prime rate publicly announced from time to time by Wells Fargo Bank, National Association, (b) the federal funds rate plus 0.50% or (c) the sum of 1% plus one-month LIBOR plus a specified margin.

On July 30, 2018, we entered into a four-year amortizing interest rate swap agreement, and on June 15, 2021, we entered into a three-year amortizing interest rate swap agreement, both with Bank of America, N.A., as part of our overall strategy to manage our exposure to market risks associated with fluctuations in interest rates on the $1.275 billion term loan facility. As a matter of policy, we only enter into transactions that we believe will be highly effective at offsetting the underlying risk and we do not use derivatives for trading or speculative purposes. Our objective is to mitigate the impact of interest expense fluctuations on our profitability related to interest rate changes by minimizing movements in future debt payments with this interest rate swap.

The first swap has an initial notional amount of $831 million and mature on July 31, 2022. The second swap has an initial notional amount of $680 million and matures on July 31, 2024. The swaps involve the receipt of floating-rate interest payments for fixed interest rate payments over the life of the agreement. We have designated these interest rate swaps as cash flow hedges. Changes in the fair value of the derivatives are recorded to other comprehensive income on the condensed consolidated statements of comprehensive loss and are reclassified to interest expense over the life of the agreements. For additional details, refer to Note 11, Derivatives, of the accompanying notes to the condensed consolidated financial statements within “Part I. Item 1. Financial Statements” of this Quarterly Report on Form 10-Q. During the three months ended July 3, 2021, we made payments of approximately $3.1 million on our interest rate swaps and recognized $3.1 million within interest expense on the condensed consolidated statement of operations. As of July 3, 2021, we had $0.1 million of interest accrued within accrued liabilities on the condensed consolidated balance sheet. A hypothetical 10% increase or decrease on market interest rates could result in a corresponding increase or decrease in annual interest expense of approximately $0.1 million.

Interest rates were lower in the three months ended July 3, 2021 compared to the same period in the prior year. In the three months ended July 3, 2021 and June 27, 2020 we generated interest income of $0.2 million and $0.0 million, respectively.

FOREIGN CURRENCY EXCHANGE RATE RISK

We are a net receiver of currencies other than the United States Dollar ("USD.") Accordingly, changes in exchange rates, and in particular a strengthening of the USD, could negatively affect our total net revenues and gross margins, as expressed in USD. There is a risk that we will have to adjust local currency product pricing due to competitive pressures if there is significant volatility in foreign currency exchange rates.

The primary currency fluctuations to which we are exposed are the Euro ("EUR"), Great Britain Pound Sterling ("GBP"), and Mexican Peso ("MXN"). We use a hedging strategy to diminish, and make more predictable, the effect of currency fluctuations. All of our hedging activities are entered into with large financial institutions, which we periodically evaluate for credit risks. We hedge our balance sheet exposure by hedging EUR and GBP denominated cash, accounts receivable, and accounts payable balances, and our economic exposure by hedging a portion of anticipated EUR and GBP denominated sales and our MXN denominated expenditures. We can provide no assurance that our strategy will be successful in the future and that exchange rate fluctuations will not materially adversely affect our business. We do not hold or issue derivative financial instruments for speculative trading purposes. While our existing hedges cover a certain amount of exposure for the upcoming fiscal year, long-term strengthening of the USD relative to the currencies of other countries in which we sell may have a material adverse impact on our financial results. In addition, our results may be adversely impacted by future changes in foreign currency exchange rates relative to original hedging contracts.

39

Table of Contents
The impact of changes in foreign currency rates recognized in other non-operating income, net was immaterial in the first quarter of Fiscal Year 2022. Although we hedge a portion of our foreign currency exchange exposure, the weakening of certain foreign currencies, particularly the EUR and GBP in comparison to the USD, could result in material foreign exchange losses in future periods.

Non-designated Hedges

We hedge our EUR and GBP denominated cash, accounts receivable, and accounts payable balances by entering into foreign exchange forward contracts. The table below presents the impact on the foreign exchange gain (loss) of a hypothetical 10% appreciation and a 10% depreciation of the USD against the forward currency contracts as of July 3, 2021 (in millions):
Currency - forward contracts Position USD Notional Value of Net Foreign Exchange Contracts Foreign Exchange Gain From 10% Appreciation of USD Foreign Exchange (Loss) From 10% Depreciation of USD
EUR Sell EUR $ 42.7  $ 4.3  $ (4.3)
GBP Sell GBP 13.1  1.3  (1.3)

Cash Flow Hedges

In the three months ended July 3, 2021, approximately 54% of our total net revenues were derived from sales outside of the U.S. and denominated primarily in EUR and GBP.

As of July 3, 2021, we had foreign currency put and call option contracts with notional amounts of approximately €100.3 million and £20.9 million denominated in EUR and GBP, respectively. Collectively, our option contracts hedge against a portion of our forecasted foreign currency denominated sales. If the USD is subjected to either a 10% appreciation or 10% depreciation versus these net exposed currency positions, we could realize a gain of $10.5 million or incur a loss of $7.9 million, respectively.

The table below presents the impact on the Black-Scholes valuation of our currency option contracts of a hypothetical 10% appreciation and a 10% depreciation of the USD against the indicated option contract type for cash flow hedges as of July 3, 2021 (in millions):
Derivative USD Notional Value of Net Foreign Exchange Contracts Foreign Exchange Gain From 10% Appreciation of USD Foreign Exchange (Loss) From 10% Depreciation of USD
Call options $ 155.5  $ 0.4  $ (7.4)
Put options 143.8  9.6  (0.9)
Forwards 122.1  12.1  (12.1)

Collectively, our swap contracts hedge against a portion of our forecasted MXN denominated expenditures. As of July 3, 2021, we had cross-currency swap contracts with notional amounts of approximately MXN 369.9 million.

The table below presents the impact on the valuation of our cross-currency swap contracts of a hypothetical 10% appreciation and a 10% depreciation of the USD as of July 3, 2021 (in millions):

Derivative USD Notional Value of Cross-Currency Swap Contracts Foreign Exchange (Loss) From 10% Appreciation of USD Foreign Exchange Gain From 10% Depreciation of USD
Position: Buy MXN $ 17.8  $ (1.8) $ 1.8 

Except as described above, there have been no material changes in our market risk as described in our Annual Report on Form 10-K for the fiscal year ended April 3, 2021.
40

Table of Contents
ITEM 4. CONTROLS AND PROCEDURES

(a)Evaluation of disclosure controls and procedures

Our management evaluated, with the participation of our Chief Executive Officer and our Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures are effective as of the end of the period covered by this report to ensure that information we are required to disclose in reports that we file or submit under the Securities Exchange Act of 1934 (i) is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

(b)Changes in internal control over financial reporting

There have been no changes in the Company’s internal control over financial reporting during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, its internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are presently engaged in various legal actions arising in the normal course of business. We believe that it is unlikely that any of these actions will have a material adverse impact on our operating results; however, because of the inherent uncertainties of litigation, the outcome of any of these actions could be unfavorable and could have a material adverse effect on our financial condition, results of operations or cash flows. For additional information about our material legal proceedings, please see Note 7, Commitments and Contingencies, of the accompanying notes to the condensed consolidated financial statements within “Part I. Item 1. Financial Statements” of this Quarterly Report on Form 10-Q..

ITEM 1A. RISK FACTORS

You should carefully consider the risk factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended April 3, 2021 ("Form 10-K"), each of which could materially affect our business, financial position, or future results of operations.

The risks described within this Quarterly Report on Form 10-Q and in the Form 10-K are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial position, or future results of operations.

41

Table of Contents
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the first quarter of Fiscal Year 2022, we did not repurchase any shares of our common stock. As of July 3, 2021, there remained 1,369,014 shares authorized for repurchase under the existing stock repurchase program. The following table presents information with respect to shares that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock grants under our stock plans:
 
Total Number of Shares Purchased (4)
 
Average Price Paid per Share (2)
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1)
Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs (3)
April 4, 2021 to May 1, 2021 —  N/A —  1,369,014 
May 2, 2021 to May 29, 2021 308,359  N/A —  1,369,014 
May 30, 2021 to July 3, 2021 8,219  N/A —  1,369,014 
(1) On November 28, 2018, our Board of Directors approved a 1 million shares repurchase program expanding our capacity to repurchase shares to approximately 1.7 million shares. We may repurchase shares from time to time in
open market transactions or through privately negotiated transactions. There is no expiration date associated with the repurchase activity.
(2) "Average Price Paid per Share" reflects open market repurchases of common stock only.
(3) These shares reflect the available shares authorized for repurchase under the expanded program approved by the Board on November 28, 2018.
(4) Represents only shares that were tendered to us in satisfaction of employee tax withholding obligations upon the vesting of restricted stock grants under our stock plans.

42

ITEM 6. EXHIBITS

We have filed the following documents as Exhibits to this Quarterly Report on Form 10-Q:

EXHIBITS INDEX
Exhibit Number     Incorporation by Reference Filed Herewith
Exhibit Description   Form File No. Exhibit Filing Date
10.1** X
10.2* X
31.1           X
31.2           X
32.1           X
101.INS XBRL Instance Document - the XBRL Instance Document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document           X
101.SCH Inline XBRL Taxonomy Extension Schema Document           X
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document           X
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document           X
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document           X
101.DEF Inline XBRL Taxonomy Definition Linkbase Document X
104 Cover Page Interactive Data File, (formatted as Inline XBRL and contained in Exhibit 101) X

*
Indicates a management contract or compensatory plan, contract or arrangement in which any Director or any Executive Officer participates.
**
Confidential treatment has been granted with respect to certain portions of this Exhibit.

43

Table of Contents
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
  PLANTRONICS, INC.
     
Date: July 30, 2021 By: /s/ Charles D. Boynton
  Name: Charles D. Boynton
  Title: Executive Vice President and Chief Financial Officer
44

345 Encinal Street
Santa Cruz, CA 95060
+1 (831) 426-5858

poly.com


June 10, 2021


Warren Schlichting


Dear Warren:

On behalf of Plantronics, Inc., now branded as Poly (the “Company”), I am pleased to offer you the position of Executive Vice President, Chief Operating Officer, reporting to Dave Shull, President & Chief Executive Officer. Should you accept this offer of employment, your first day of employment is anticipated to be on or about June 14, 2021 (your actual first day of employment is referred to as the “start date”).

This letter outlines the terms of your employment with the Company as of your start date, including your compensation and benefits, as set forth below:

Annualized Base
$525,000 per year, payable biweekly in accordance with our standard payroll practices and less applicable tax withholding.
Salary
Annual Incentive
80% of your Annual Base Salary, or $420,000, at target performance, subject to the terms of the Plantronics, Inc. Annual Incentive Plan (“AIP”).
Plan
The purpose of the AIP is to focus participants on achieving annual Company-wide financial performance goals as well as product group, segment, or functional objectives and individual performance goals, as determined by the Company’s Leadership Development and Compensation Committee (“LD&C Committee”) from time to time, by providing the opportunity to receive annual cash payments based on accomplishments of those goals during the year.
Target Total Cash
Up to $945,000 per year based on the compensation elements shown above assuming at target performance. There is no guarantee that total cash compensation will be achieved.
Compensation
Signing Bonus
The Company is advancing you a Signing Bonus of $200,000, less applicable deductions and withholdings (the “Signing Bonus”).










New Hire
It will be recommended to the Company’s LD&C Committee that you receive an equity award of 28,125 shares of the Company’s common stock in the form of a restricted stock units (“RSUs”). If approved by the LD&C Committee, the price to you of the RSUs will be $0.00 and the RSUs will be awarded and subject to the Plantronics, Inc. 2003 Equity Incentive Plan, as amended and restated from time to time, and the RSU agreement in effect at the time of grant (the “RSU Documents”). If approved, the RSUs will vest and be released from escrow or settled in accordance with the terms of the RSU Documents; provided, however, any RSUs that would otherwise vest and be released from escrow or settled on December 31st of any year shall instead vest on January 2nd of the succeeding year. All vesting is subject to your continued employment with the Company on each applicable vesting date.
Restricted Stock
Units
Performance-
It will be recommended to the Company’s LD&C Committee that you receive an equity award of 65,625 of the Company’s common stock in the form of performance-based restricted stock units (“PSUs”), with the performance period aligned to the FY22 performance-based performance goals and payout plan (the “PSU Plan”) and earnable over the three-year performance period. If approved by the LD&C Committee, the price to you of the PSUs will be $0.00 and the PSUs will be awarded and subject to the PSU Plan, the Equity Incentive Plan and the PSU agreement in effect at the time of grant (the “PSU Documents”). If approved, the PSUs will vest and be released from escrow or settled in accordance with the PSU Documents. All vesting is subject achievement of the applicable performance goals specified in the PSU Documents and to your continued employment on each applicable vesting date.
based Restricted
Stock Units
Severance
As of your start date, you will be provided with the Company’s executive severance agreement in effect and as approved by the Company’s LD&C Committee for your job level (“Executive Severance Agreement”). The Executive Severance Agreement contains severance benefits payable to you should your employment with the Company be terminated other than for cause, subject to the terms of the Executive Severance Agreement including, without limitation, your execution of the Company’s standard form of release agreement then in effect. You will be eligible to participate in the Company’s executive severance benefit as available or that become available to other similarly situated executives of the Company, subject to the generally applicable terms and conditions then in effect.
Agreement
Change-in-Control
As of your start date, you will be provided with change of control severance protection approved by the Company’s LD&C Committee for your job level, which will be included as Exhibit A to your Executive Severance Agreement (the “CoC Agreement”). The CoC Agreement contains severance benefits payable to you should your employment with the Company be terminated, other than for cause, in connection with a “Change of Control” event (as defined in the CoC Agreement, subject to the terms of the CoC Agreement including, without limitation, your execution of the Company’s standard form of release agreement then in effect.
Benefits



General Benefits
You will be eligible to participate in the Company’s benefit programs as available or that become available to other similarly situated employees of the Company, subject to the generally- applicable terms and conditions of each program. The continuation or termination of each program will be at the discretion of the Company. Life, Medical, Dental and Disability coverage will begin on your start date.

Executive
You will be automatically enrolled in our Executive Health Exam Program, if and to the extent such program continues to remain in effect and is offered to employees at your level. This program is aimed to give you guidance and direction on further health items on which to follow up. To qualify, you must schedule the appointment through the pre-identified network of doctors.
Physical Program
401(k)
You are eligible to join the Company’s 401(k) plan, subject to the terms and condition of the plan document.
Non-Qualified
You will be eligible to participate in a non-qualified deferred compensation plan, subject to the terms and conditions of the plan document. An eligible participant may elect to defer prospective compensation not yet earned by submitting a Compensation Deferral Agreement during the enrollment periods. For more information regarding the Company’s Deferred Compensation Plan, please see the Prospectus.
Deferred
Compensation
Plan
ESPP
You will be eligible to participate in the Company’s Employee Stock Purchase Plan, subject to the terms of the plan document.

This formal notification of our offer of employment is subject to the terms set forth in your Employment Application which you have submitted to the Company and is contingent upon satisfactory background verification, receipt of an original application, a final review of references, your completion of a D&O Questionnaire resulting in no conflicts of interest, and the LD&C Committee’s approval of the terms of this letter.

As a condition of your employment, you will also be required to sign and comply with: Warren Schlichting - New Hire Certification – Prior Employer Confidential Information, which requires, among other things, you to certify that you may have had access to a prior employer’s confidential, proprietary or trade secret information, you have not downloaded or otherwise transferred any of that information to any device, you or your prior employer have deleted that information from any of your devices and/or returned that information to your prior employer and you will not use any such information during your employment with the Company.

For purposes of federal immigration law, you will be required to provide to the Company documentary evidence of your identity and eligibility for employment in the United States. Such documentation must be provided to the Company within 3 business days of your start date, or our employment relationship with you may be immediately terminated.

Before releasing certain export-controlled technology and software to you during your employment at the Company, the Company may be required to obtain an export license in accordance with United States law. The Company will inform you if an export license is needed. If an export license is required, then this offer of employment and/or your continued employment (if applicable) with the Company is contingent upon receipt of the export license or authorization, and the Company will have no obligation to employ you or provide you with any compensation or benefits until the export license or authorization is secure.




Please be aware that your employment with the Company is for no specified period and constitutes at-will employment. As a result, you are free to resign at any time, for any reason or for no reason. Similarly, the Company is free to conclude its employment relationship with you at any time, with or without cause, and with or without notice. We request that, in the event of resignation, you give the Company at least two weeks’ prior notice.

You agree that, during the term of your employment with the Company, you will devote substantially all of your professional time to fulfill your responsibilities at the Company, and you will not engage in any other employment, occupation, consulting or other business activity directly related to the business in which the Company is now involved or becomes involved during the term of your employment, nor will you engage in any other activities that conflict with your obligations to the Company, except that the Company acknowledges and agrees that you may continue to be employed by the Special Purposes Acquisition Company (“SPAC”) in the position in which you currently serve, and to provide continued consulting services to your private equity firm, provided that the number of hours of service does not exceed approximately ten (10) and five (5) hours, respectively, per month, and further subject to the limitations outlined above. You further agree that should the SPAC engage in de-SPAC activities, you will promptly notify and consult with the Company’s Chief Legal and Compliance Officer as to whether and when you may be obligated to resign such position.

As a Company employee, you are required to abide by Company rules and standards as presented in our Employee Handbook, our Worldwide Code of Business Conduct and Ethics and other Company policies.

As a condition of your employment, you will also be required to sign and/or otherwise comply with:

Non-Solicitation of Employees: You agree that for a period of 12 months following your separation of employment with the Company, you shall not, either personally or in conjunction with others, solicit, interfere with, or endeavor to cause anyone employed by the Company whom you supervised, with whom you worked in providing service to customers, or about whom you received confidential information, in any such case within the last 12 months preceding the termination of your employment with Company, to leave such employment. Nothing in this paragraph is meant to prohibit an employee of Company that is not a party hereto from becoming employed by another person or entity.

Employee, Confidential Information, and Invention Assignment Agreement which requires, among other provisions, (i) the assignment of patent, copyright and other intellectual property rights to any invention made during your employment at the Company, and (ii) non-disclosure of proprietary information.

Export Compliance: Before releasing certain export-controlled technology and software to you during your employment at the Company, the Company may be required to obtain an export license in accordance with United States law. The Company will inform you if an export license is needed. If an export license is required, then this offer of employment and/or your continued employment (if applicable) with the Company is contingent upon receipt of the export license or authorization, and the Company will have no obligation to employ you or provide you with any compensation or benefits until the export license or authorization is secure.

All payments and benefits under this letter are subject to applicable tax and other withholdings. To the extent that reimbursements or other in-kind benefits under this letter constitute “nonqualified deferred compensation” for purposes of Internal Revenue Code section 409A, (i) all expenses or other reimbursements hereunder shall be made on or prior to the last day of the taxable year following the taxable year in which such expenses were incurred by you, (ii) any right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, (iii) no such reimbursement, expenses eligible for reimbursement, or in-kind benefits provided in any taxable year shall in any way affect the expenses eligible for reimbursement, or in-kind benefits to be provided, in any other taxable year, and (iv) except as specifically provided herein or in the applicable reimbursement arrangement, any such reimbursements or in-kind benefits must be for expenses incurred and benefits provided during the



your lifetime. In no event will the Company be held liable for any taxes, interest, penalties or other amounts owed by Employee under Code Section 409A.

To indicate your acceptance of the Company’s offer of employment as stated above, please sign and date this letter in the space provided below. This letter sets forth the terms of your employment with the Company and supersedes any prior representations or agreements, whether written or oral. This letter, including, but not limited to, its at-will employment provision, may not be modified or amended except by a written agreement signed by the Company’s CEO and you.




















































I look forward to working with you and having you as a member of the team!


Sincerely,
PLANTRONICS, INC.

/s/ Anja Hamilton
Anja Hamilton
EVP & Chief Human Resources Officer













Agreed to and accepted:

Signature:        /s/ Warren Schlichting

Printed Name:        Warren Schlichting


Received Offer Date:     June 10, 2021


Confirmed Start Date:     June 14, 2021



This offer expires one week from the date listed on the first page.
Please scan/email a signed copy to indicate acceptance of offer.



PLANTRONICS, INC.
EXECUTIVE SEVERANCE AGREEMENT
This Executive Severance Agreement (this “Agreement”) is made and entered into by and between Warren Schlichting (“Executive”) and Plantronics, Inc., a Delaware corporation (the “Company”), effective as of June 14, 2021 (the “Effective Date”).
RECITALS
1.Executive is employed by the Company or one of its affiliates in a key employee
capacity and the Executive’s services are valuable to the conduct of the business of the Company.
2.The Compensation and Leadership Development Committee of the Board of Directors (“Board”) of the Company (the “Committee”) believes it is in the best interests of the Company and its stockholders to specify the terms and conditions on which Executive will receive severance in the event that Executive separates from service with the Company and its affiliates under the circumstances set forth in this Agreement.
3.Certain capitalized terms used in the Agreement are defined in Section 6 below.
AGREEMENT
NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties
hereto agree as follows:
1.Term of Agreement. This Agreement will have an initial term of three (3) years commencing on the Effective Date (the “Initial Term”). On the third anniversary of the Effective Date and thereafter, this Agreement will renew automatically for successive one (1) year terms (the “Additional Terms”) unless either party provides the other party with written notice of non-renewal at least sixty (60) days prior to the date of automatic renewal. If Executive becomes entitled to benefits under Section 4 during the Initial Term or any Additional Term, this Agreement will not terminate until all of the obligations of the parties hereto with respect to this Agreement have been satisfied.
2.At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and will continue to be at-will, as defined under applicable law. If Executive’s employment terminates for any reason, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this Agreement or as provided in any employment agreement entered into between the Company and Executive, and the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses.
1


3.Change of Control. Notwithstanding anything to the contrary herein, in the event of a Change of Control, the Change of Control Severance Agreement set forth in Exhibit A shall supersede and replace this Agreement in all respects.
4.Severance Benefits.
    (a)     Termination without Cause. If the Company terminates Executive’s employment with the Company without Cause, and Executive signs and does not revoke a release of claims with the Company (in a form reasonably acceptable to the Company) (“Release”) and provided that such Release becomes effective and irrevocable no later than sixty (60) days following the termination date or such earlier date required by the Release (such deadline, the “Release Deadline”), then subject to the terms and conditions in this Section 4, Executive will receive the following:
(i)Accrued Compensation. The Company will pay Executive all accrued
but unpaid salary, bonus, expense reimbursements, wages, and other benefits due to Executive under any plans, policies, and arrangements provided by the Company or its affiliates, subject to the limitations set forth in subsection (ii).
(ii)Severance Payments. Executive will receive (A) continuing payment
(less applicable withholding taxes), in accordance with the timing and process of the Company’s or its affiliates’ regular payroll practices (subject to the timing provisions of Section 4(b)), of Executive’s annual base salary as in effect immediately prior to Executive’s termination date for a period of eighteen (18) months following Executive’s termination of employment; and (B) a lump sum cash payment, to be made on the first regular payroll date following sixty (60) days after the date of termination, equal to 100% of Executive’s annual target incentive bonus for the year in which the termination of employment occurs or, if Executive’s target incentive bonus has not yet been established for the year, the prior year’s target incentive bonus (in each case, less applicable withholding taxes) (the “Bonus Payment”). For the avoidance of doubt, the Bonus Payment shall be in lieu of, not in addition to, any quarterly or annual bonus to which Executive would otherwise become entitled for performance during the year in which the termination of employment occurs.
(iii)COBRA. If Executive timely elects continued group health plan
continuation coverage under COBRA or a state or local equivalent, then the Company shall pay the full amount of Executive’s premiums on behalf of Executive for Executive’s continued coverage under the Company’s group health plans, including coverage for Executive’s eligible dependents, for eighteen (18) months or until such earlier date on which Executive becomes eligible for health coverage from another employer (the “COBRA Payment Period”). The level of coverage will be the same (if possible) as the level of coverage selected by Executive and in effect at the time of Executive’s termination. Notwithstanding the foregoing, if Executive timely elects continued group health plan
2


continuation coverage under COBRA and at any time thereafter the Company determines, in its sole discretion, that it cannot provide the COBRA premium benefits without potentially incurring financial costs or penalties under applicable law or violating Section 105(h) of the Internal Revenue Code of 1986, as amended (the “Code”), then in lieu of paying the employer portion of the COBRA premiums on Executive’s behalf, the Company will instead pay to Executive on the last day of each remaining month of the COBRA Payment Period a fully taxable cash payment equal to 200% of the COBRA premium for that month, subject to applicable tax withholding (such amount, the “Special Severance Payments”). Such Special Severance Payments shall end upon expiration of the COBRA Payment Period.

(iv)Outplacement. The Company will provide reasonable and customary
outplacement assistance to Executive at the Company’s cost for eighteen (18) months following termination of employment.
(v)Equity Awards. Any equity awards (including, without limitation, any
awards of stock options, restricted stock, restricted stock units, and/or performance shares or units that have been granted), outstanding as of the date of such termination will be treated as provided in the applicable plan document and award agreement.
    (b)     Timing of Payments.
(i)If the Release does not become effective and irrevocable by the Release Deadline, Executive will forfeit any rights to severance or benefits under this Agreement. In no event will the payments or benefits contemplated by Section 4(a)(ii)-(v) be paid or provided until the Release actually becomes effective and irrevocable. Any payments or benefits under Section 4(a) that would be considered Deferred Compensation Severance Benefits (as defined in Section 4(h)(i)) will be paid on, or, in the case of installments, will not commence until, the sixtieth (60th) day following Executive’s separation from service, or, if later, such time as required by Section 4(h). Except as required by Section 4(h), any installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive’s separation from service but for the preceding sentence will be paid to Executive on the sixtieth (60th) day following Executive’s separation from service and the remaining payments will be made as provided in this Agreement.
(ii)If Executive should die before amounts payable pursuant to Section 4(a)(i)(ii) and (v) have been paid, such unpaid amounts will be paid in a lump-sum payment promptly following such event to Executive’s designated beneficiary, if living, or otherwise to the personal representative of Executive’s estate.
    (c)     Voluntary Resignation; Termination for Cause. If Executive’s employment
3


with the Company is terminated voluntarily by Executive or for Cause by the Company, then:
(i)Accrued Compensation and Benefits. The Company will pay Executive
all accrued but unpaid salary, bonus, expense reimbursements, wages, and other benefits due to Executive under any plans, policies, and arrangements provided by the Company or its affiliates.
(ii)Severance or Other Benefits. Executive will not be entitled to receive
severance or other benefits under this Agreement.
    (d)     Disability; Death. If the Company terminates Executive’s employment as a
result of Executive’s Disability, or Executive’s employment terminates due to his or her death, then:
(i)Accrued Compensation and Benefits. The Company will pay Executive
all accrued but unpaid salary, bonus and vacation, expense reimbursements, wages, and other benefits due to Executive under any plans, policies, and arrangements provided by the Company or its affiliates.

(ii)Severance or Other Benefits. Executive will not be entitled to receive severance or other benefits except for those (if any) as may then apply to Executive under the Company’s or its affiliates’ then existing benefits plans and practices to the extent applicable.
(e)Exclusive Remedy. In the event of a termination of Executive’s employment as set forth in Section 4(a), the provisions of Section 4 are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses).
(f)Section 409A.
(i)Notwithstanding anything to the contrary in this Agreement, no severance payments or other benefits payable to Executive, if any, pursuant to this Agreement, when considered together with any other severance payments or other benefits that are considered deferred compensation under Section 409A of the Code (“Section 409A”) (together, the “Deferred Compensation Separation Benefits”) will be payable until Executive has a “separation from service” within the meaning of Section 409A.
4


(ii)Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s termination (other than due to death), then, to the extent required for compliance with Section 409A, any Deferred Compensation Separation Benefits that are payable as a result of Executive’s separation from service within the first six (6) months following Executive’s separation from service will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive’s separation from service. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following Executive’s separation from service but prior to the six (6) month anniversary of the separation, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive’s death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to constitute a separate payment for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.
(iii)Any amount paid under this Agreement that satisfies the requirements
of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.
(iv)Any amount paid under this Agreement that qualifies as a payment made
as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that do not exceed the Section 409A Limit will not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.
(v)The foregoing provisions are intended to comply with the requirements
of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.
(g) Other Requirements. Executive’s receipt of any payments or benefits under this Section 4 will be subject to Executive continuing to comply with the terms of any confidential information agreement executed by Executive in favor of the Company and the provisions of this Agreement.
5.Limitation on Payments. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code, and (ii) but for this Section 5,
5


would be subject to the excise tax imposed by Section 4999 of the Code, then Executive’s benefits under Section 3 and Section 4(a) respectively will be either:
(a)delivered in full, or
(b)delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code,
whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. If a reduction in severance and other benefits constituting “parachute payments” is necessary so that benefits are delivered to a lesser extent, reduction will occur in the following order reduction of cash payments; cancellation of awards granted “contingent on a change in ownership or control” (within the meaning of Code Section 280G), cancellation of accelerated vesting of equity awards; reduction of employee benefits. In the event that acceleration of vesting of equity award compensation is to be reduced, such acceleration of vesting will be cancelled in the reverse order of the date of grant of Executive’s equity awards.
Unless the Company and Executive otherwise agree in writing, any determination required under this Section 5 will be made in writing by the Company’s independent public accountants immediately prior to a Change of Control or such other person or entity to which the parties mutually agree (the “Accountants”), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 5, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company will bear all costs the Accountants may incur in connection with any calculations contemplated by this Section 5.
6.Definition of Terms. The following terms referred to in this Agreement will have the following meanings:
(a)Cause. “Cause” will mean Executive’s termination only upon:
(i)Executive’s willful failure (A) to comply with the Company’s policies and practices applicable to the Company’s employees in similar job positions or to the Company’s employees generally or (B) to follow the reasonable instructions of Executive’s supervisor;
(ii)Executive’s engaging in willful misconduct which is demonstrably and materially injurious to the Company;
6


(iii)Executive’s committing a felony, an act of fraud against, or the misappropriation of property belonging to the Company; or
(iv)Executive’s breaching in any material respect the terms of this Agreement or the Employee Patent, Secrecy and Invention Agreement between Executive and the Company.
(b)Change of Control. “Change of Control” will mean the occurrence of any of the following events:
(i)Change in Ownership of the Company. A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the Company, except that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Company’s Board will not be considered a Change of Control; or
(ii)Change in Effective Control of the Company. A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change of Control; or

(iii)Change in Ownership of a Substantial Portion of the Company’s Assets. A change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

For these purposes, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.
7


Notwithstanding the foregoing provisions of this definition, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within the meaning of Section 409A.
(c)Disability. “Disability” will mean that Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months. Termination resulting from Disability may only be effected after at least thirty (30) days’ written notice by the Company of its intention to terminate Executive’s employment. In the event that Executive resumes the performance of substantially all of his or her duties hereunder before the termination of his or her employment becomes effective, the notice of intent to terminate will automatically be deemed to have been revoked.
(d)Section 409A Limit. “Section 409A Limit” will mean the lesser of two (2) times: (i) Executive’s annualized compensation based upon the annual rate of pay paid to Executive during the Executive’s taxable year preceding the Executive’s taxable year of Executive’s termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s employment is terminated.
7.Successors.
(a)The Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” will include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this Section 7(a) or which becomes bound by the terms of this Agreement by operation of law.

(b)Executive’s Successors. The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.
8.Notice.
(a)General. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid or when delivered by a private courier service such as UPS, DHL or
8


Federal Express that has tracking capability. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its Chief Executive Officer with a copy to its Chief Legal Officer.
(b)Notice of Termination. Any termination by the Company for Cause will be communicated by a notice of termination to Executive hereto given in accordance with Section 8(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination for Cause, and will specify the termination date (which will be not more than ninety (90) days after the giving of such notice).
9.Miscellaneous Provisions.
(a)No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source.

(b)Waiver. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.
(c)Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.

(d)Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement.
(e)Choice of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State of California (with the exception of its conflict of laws provisions). Any claims or legal actions by one party against the other arising out of the relationship between the parties contemplated herein (whether or not arising under this Agreement) will be commenced or maintained in any state or federal court located in the jurisdiction where Executive resides, and Executive and the Company hereby submit to the jurisdiction and venue of any such court.
9


(f)Severability. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect.
(g)Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes.
(h)Counterparts and Electronic Signature. This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. Delivery of an executed counterpart of this Agreement by facsimile transmission or in portable document format or similar electronic form by email shall constitute due and effective delivery thereof.





[Signature Page to Follow]


10


IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of June 14, 2021.

COMPANY    PLANTRONICS, INC.


By:     /s/ David Shull     

Name: David Shull

Title:    President & Chief Executive Officer    

Date:    _June 14, 2021_____________________



EXECUTIVE     By:     /s/ Warren Schlichting    

Name: Warren Schlichting

Title:     Executive Vice President, Chief
Operating Officer

Date:     June 14, 2021    


11


Exhibit A
PLANTRONICS, INC.
CHANGE OF CONTROL SEVERANCE AGREEMENT

This Change of Control Severance Agreement (the “Agreement”) is made and entered into by and between Warren Schlichting (“Executive”) and Plantronics, Inc., a Delaware corporation (the “Company”), effective as of June 14, 2021 (the “Effective Date”).

RECITALS

1.It is expected that the Company from time to time will consider the possibility of an acquisition by another company or other change of control. The Leadership Development and Compensation Committee (the “Committee”) of the Board of Directors (“Board”) of the Company recognizes that such consideration can be a distraction to certain executives and can cause them to consider alternative employment opportunities. The Committee has determined that it is in the best interests of the Company and its stockholders to assure that the Company will have the continued dedication and objectivity of Executive, notwithstanding the possibility, threat or occurrence of a Change of Control of the Company.

2.The Committee believes that it is in the best interests of the Company and its stockholders to provide Executive with an incentive to continue his or her employment and to motivate Executive to maximize the value of the Company upon a Change of Control for the benefit of its stockholders.

3.The Committee believes that it is imperative to provide Executive with certain severance benefits upon Executive’s termination of employment following a Change of Control. These benefits will provide Executive with enhanced financial security and incentive and encouragement to remain with the Company notwithstanding the possibility of a Change of Control.

4.Certain capitalized terms used in the Agreement are defined in Section 6 below.

AGREEMENT

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:

1.Term of Agreement. This Agreement will have a term of two (2) years commencing on the Effective Date (the “Term”) unless either party provides the other party with written notice of termination at least sixty (60) days in advance. Notwithstanding the foregoing sentence, if a Change of Control occurs at any time during the Term, the term of this Agreement will extend automatically through the date that is twenty-four (24) months following the effective date of the Change of Control. If Executive becomes entitled to benefits under Section 3 or
12


Section 4 during the term of this Agreement, the Agreement will not terminate until all of the obligations of the parties hereto with respect to this Agreement have been satisfied.

2.At-Will Employment. The Company and Executive acknowledge that Executive’s employment is and will continue to be at-will, as defined under applicable law. If Executive’s employment terminates for any reason, including (without limitation) any termination that occurs other than during the period that is on or within twenty-four (24) months after a Change of Control as provided herein, Executive will not be entitled to any payments, benefits, damages, awards or compensation other than as provided by this Agreement or as provided in any employment agreement entered into between the Company and Executive, and the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses.

3.Change of Control. In the event of a Change of Control, and subject to Executive’s continued employment with the Company through the effective date of such Change of Control, all outstanding equity awards will vest according to the vesting schedule specified in the 2003 Stock Plan, as amended and/or amended and restated from time to time.

4.Severance Benefits.

(a)Termination without Cause or Resignation for Good Reason in Connection with a Change of Control. If the Company terminates Executive’s employment with the Company without Cause or if Executive resigns from such employment for Good Reason, and such termination occurs on or within twenty-four (24) months after a Change of Control, and Executive signs and does not revoke a release of claims with the Company (in a form reasonably acceptable to the Company) and provided that such release of claims becomes effective no later than sixty (60) days following the termination date or such earlier date required by the release agreement (such deadline, the “Release Deadline”), then subject to this Section 4, Executive will receive the following:

(i)Accrued Compensation. The Company will pay Executive all accrued but unpaid wages, expense reimbursements and other benefits due to Executive under any Company-provided plans, policies, and arrangements.

(ii) Severance Payment. Executive will receive a lump-sum payment (less applicable withholding taxes) equal to the sum of (A) 78 weeks of Executive’s annual base salary as in effect immediately prior to Executive’s termination date or (if greater) at the level in effect immediately prior to the Change of Control, (B) 78 weeks of Executive’s target annual incentive bonus as in effect immediately prior to Executive’s termination date or (if greater) at the level in effect immediately prior to the Change of Control, and (C) that pro-rata portion of 52 weeks of Executive’s annual incentive bonus as measured by the beginning of quarter (“BOQ”) accrual for the incentive bonus Executive has earned but not yet been paid (disregarding the requirement that the participant must have been employed by the Company as of the date of payout to earn any portion of or all of their annual incentive bonus).

13


(ii)Continued Employee Benefits. If Executive elects continuation coverage pursuant to the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) or the California Continuation Benefits Replacement Act, as amended (“Cal-COBRA”) for periods of coverage beyond that permitted by COBRA for Executive and Executive’s eligible dependents, within the time period prescribed pursuant to COBRA, or Cal-COBRA, as applicable, the Company will reimburse Executive for the COBRA (or, if applicable, Cal-COBRA) premiums for such coverage (at the coverage levels in effect immediately prior to Executive’s termination) until the earlier of (A) a period of 24 months from the last date of employment of the Executive with the Company, or (B) the date upon which Executive and/or Executive’s eligible dependents becomes covered under similar plans. COBRA (or, if applicable, Cal-COBRA) reimbursements will be made by the Company to Executive consistent with the Company’s normal expense reimbursement policy. However, if the Company determines in its sole discretion that it cannot provide the COBRA or Cal- COBRA benefits without potentially violating applicable law (including, without limitation, Section 2716 of the Public Health Service Act), the Company will in lieu thereof provide to Executive a taxable monthly payment in an amount equal to the monthly COBRA (or, if applicable, Cal-COBRA) premium that Executive would be required to pay to continue his or her group health coverage in effect on the date of his or her termination of employment (which amount will be based on the premium for the first month of COBRA coverage), which payments will be made regardless of whether Executive elects COBRA, or Cal-COBRA, as applicable, continuation coverage.

(iii)Outplacement Services. Key Employee will be entitled to 18 months of outplacement services.

(iv)Equity Awards. Any equity awards (including, without limitation, any awards of stock options, restricted stock, restricted stock units, and/or performance shares or units) outstanding as of the date of such termination will vest in full as to 100% of the unvested portion of the award, including performance shares at target.

(v)Timing of Payments.

(1)If the release of claims does not become effective by the Release Deadline, Executive will forfeit any rights to severance or benefits under this Agreement. In no event will severance payments or benefits be paid or provided until the release of claims actually becomes effective. Any severance payments or benefits under this Agreement that would be considered Deferred Compensation Severance Benefits (as defined in Section 4(f)(i)) will be paid on, or, in the case of installments, will not commence until, the sixtieth (60th) day following Executive’s separation from service, or, if later, such time as required by Section 4(f). Except as required by Section 4(f), any installment payments that would have been made to Executive during the sixty (60) day period immediately following Executive’s separation from service but for the preceding sentence will be paid to Executive on the sixtieth (60th) day following Executive’s separation from service and the remaining payments will be made as provided in this Agreement.

14


(2)Unless otherwise required by Section 4(a)(v)(1) or Section 4(f), the Company will pay any severance payments in a lump-sum payment payable within thirty (30) days following Executive’s termination date; provided, however, that no severance or other benefits will be paid or provided until the release of claims discussed in Section 4(a) becomes effective and irrevocable, and any severance amounts or benefits otherwise payable between Executive’s termination date and the date such release becomes effective and irrevocable will be paid on the date the release becomes effective and irrevocable. If Executive should die before all of the severance amounts have been paid, such unpaid amounts will be paid in a lump-sum payment promptly following such event to Executive’s designated beneficiary, if living, or otherwise to the personal representative of Executive’s estate.

(b)Voluntary Resignation; Termination for Cause. If Executive’s employment with the Company terminates (i) voluntarily by Executive (other than for Good Reason during the period that is on or within twenty-four (24) months after a Change of Control) or (ii) for Cause by the Company, then Executive will not be entitled to receive severance or other benefits except for those (if any) as may then be established under the Company’s then existing severance and benefits plans and practices or pursuant to other written agreements with the Company.

(c)Disability; Death. If the Company terminates Executive’s employment as a result of Executive’s Disability, or Executive’s employment terminates due to his or her death, then Executive will not be entitled to receive any other severance or other benefits except for those (if any) as may then be established under the Company’s then existing written severance and benefits plans and practices or pursuant to other written agreements with the Company.

(d)Termination not in Connection with a Change of Control. In the event Executive’s employment is terminated for any reason other than as provided in Section 4(a), then Executive will be entitled to receive severance and any other benefits only as may then be established under the Company’s existing written severance and benefits plans and practices or pursuant to other written agreements with the Company.

(e)Exclusive Remedy. In the event of a Change of Control, or a termination of Executive’s employment as set forth in Section 4(a) of this Agreement, the provisions of Section 3 and Section 4 are intended to be and are exclusive and in lieu of any other rights or remedies to which Executive or the Company may otherwise be entitled, whether at law, tort or contract, in equity, or under this Agreement (other than the payment of accrued but unpaid wages, as required by law, and any unreimbursed reimbursable expenses).

(f)Section 409A.

(i)Notwithstanding anything to the contrary in this Agreement, no severance payable to Executive, if any, pursuant to this Agreement, when considered together with any other severance payments or separation benefits that are considered deferred compensation under Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) and the final regulations and any guidance promulgated thereunder (“Section 409A”)
15


(together, the “Deferred Compensation Separation Benefits”) will be payable until Executive has a “separation from service” within the meaning of Section 409A.

(ii)Notwithstanding anything to the contrary in this Agreement, if Executive is a “specified employee” within the meaning of Section 409A at the time of Executive’s termination (other than due to death), then the Deferred Compensation Separation Benefits that are payable within the first six (6) months following Executive’s separation from service, will become payable on the first payroll date that occurs on or after the date six (6) months and one (1) day following the date of Executive’s separation from service. All subsequent Deferred Compensation Separation Benefits, if any, will be payable in accordance with the payment schedule applicable to each payment or benefit. Notwithstanding anything herein to the contrary, if Executive dies following Executive’s separation from service but prior to the six (6) month anniversary of the separation, then any payments delayed in accordance with this paragraph will be payable in a lump sum as soon as administratively practicable after the date of Executive’s death and all other Deferred Compensation Separation Benefits will be payable in accordance with the payment schedule applicable to each payment or benefit. Each payment and benefit payable under this Agreement is intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.

(iii)Any amount paid under this Agreement that satisfies the requirements of the “short-term deferral” rule set forth in Section 1.409A-1(b)(4) of the Treasury Regulations will not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.

(iv)Any amount paid under this Agreement that qualifies as a payment made as a result of an involuntary separation from service pursuant to Section 1.409A-1(b)(9)(iii) of the Treasury Regulations that do not exceed the Section 409A Limit (as defined below) will not constitute Deferred Compensation Separation Benefits for purposes of clause (i) above.

(v)The foregoing provisions are intended to comply with the requirements of Section 409A so that none of the severance payments and benefits to be provided hereunder will be subject to the additional tax imposed under Section 409A, and any ambiguities herein will be interpreted to so comply. The Company and Executive agree to work together in good faith to consider amendments to this Agreement and to take such reasonable actions which are necessary, appropriate or desirable to avoid imposition of any additional tax or income recognition prior to actual payment to Executive under Section 409A.

(g)Other Requirements. Executive’s receipt of any payments or benefits under this Section 4 will be subject to Executive continuing to comply with the terms of any confidential information agreement executed by Executive in favor of the Company and the provisions of this Agreement. In addition, as an express condition to Executive’s right to receive any payments or benefits under this Section 4, Executive agrees that for a period of two years following Executive’s termination of employment with the Company, Executive will not solicit, encourage, or induce any other employee of the Company to terminate his or her employment
16


with the Company. The foregoing will not prohibit Executive or any entity with which Executive may be affiliated frond hiring a current or former employee of the Company.

5.Limitation on Payments. In the event that the severance and other benefits provided for in this Agreement or otherwise payable to Executive (i) constitute “parachute payments” within the meaning of Section 280G of the Code, and (ii) but for this Section 5, would be subject to the excise tax imposed by Section 4999 of the Code, then Executive’s benefits under Section 3 and Section 4(a) respectively will be either:

(a)delivered in full, or

(b)delivered as to such lesser extent which would result in no portion of such benefits being subject to excise tax under Section 4999 of the Code, whichever of the foregoing amounts, taking into account the applicable federal, state and local income taxes and the excise tax imposed by Section 4999, results in the receipt by Executive on an after-tax basis, of the greatest amount of benefits, notwithstanding that all or some portion of such benefits may be taxable under Section 4999 of the Code. If a reduction in severance and other benefits constituting “parachute payments” is necessary so that benefits are delivered to a lesser extent, reduction will occur in the following order reduction of cash payments; cancellation of awards granted “contingent on a change in ownership or control” (within the meaning of Code Section 280G), cancellation of accelerated vesting of equity awards; reduction of employee benefits. In the event that acceleration of vesting of equity award compensation is to be reduced, such acceleration of vesting will be cancelled in the reverse order of the date of grant of Executive’s equity awards.

Unless the Company and Executive otherwise agree in writing, any determination required under this Section 5 will be made in writing by the Company’s independent public accountants immediately prior to a Change of Control or such other person or entity to which the parties mutually agree (the “Accountants”), whose determination will be conclusive and binding upon Executive and the Company for all purposes. For purposes of making the calculations required by this Section 5, the Accountants may make reasonable assumptions and approximations concerning applicable taxes and may rely on reasonable, good faith interpretations concerning the application of Sections 280G and 4999 of the Code. The Company and Executive will furnish to the Accountants such information and documents as the Accountants may reasonably request in order to make a determination under this Section. The Company will bear all costs the Accountants may incur in connection with any calculations contemplated by this Section 5.

6.Definition of Terms. The following terms referred to in this Agreement will have the following meanings:

(a)Cause. “Cause” will mean Executive’s termination only upon:

(i)Executive’s willful failure, after receipt of at least one written warning, (A) to comply with the Company’s policies and practices applicable to the Company’s
17


employees in similar job positions or to the Company’s employees generally or (B) to follow the reasonable instructions of Executive’s supervisor;

(ii)Executive’s engaging in willful misconduct which is demonstrably and materially injurious to the Company;
(iii)Executive’s committing a felony, an act of fraud against, or the misappropriation of property belonging to the Company; or

(iv)Executive’s breaching in any material respect the terms of this Agreement or the Employee Patent, Secrecy and Invention Agreement between Executive and the Company.

(b)Change of Control. “Change of Control” will mean the occurrence of any of the following events:

(i)Change in Ownership of the Company. A change in the ownership of the Company which occurs on the date that any one person, or more than one person acting as a group (“Person”), acquires ownership of the stock of the Company that, together with the stock held by such Person, constitutes more than 50% of the total voting power of the stock of the Company, except that any change in the ownership of the stock of the Company as a result of a private financing of the Company that is approved by the Company’s Board of Director (the “Board”) will not be considered a Change of Control; or

(ii)Change in Effective Control of the Company. A change in the effective control of the Company which occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by directors whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purposes of this clause (ii), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Change of Control; or

(iii)Change in Ownership of a Substantial Portion of the Company’s Assets. A change in the ownership of a substantial portion of the Company’s assets which occurs on the date that any Person acquires (or has acquired during the twelve (12) month period ending on the date of the most recent acquisition by such person or persons) assets from the Company that have a total gross fair market value equal to or more than 50% of the total gross fair market value of all of the assets of the Company immediately prior to such acquisition or acquisitions. For purposes of this subsection (iii), gross fair market value means the value of the assets of the Company, or the value of the assets being disposed of, determined without regard to any liabilities associated with such assets.

For these purposes, persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company.

18


Notwithstanding the foregoing provisions of this definition, a transaction will not be deemed a Change of Control unless the transaction qualifies as a change in control event within the meaning of Section 409A.

(c)Disability. “Disability” will mean that Executive is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than twelve (12) months. Termination resulting from Disability may only be effected after at least thirty (30) days’ written notice by the Company of its intention to terminate Executive’s employment. In the event that Executive resumes the performance of substantially all of his or her duties hereunder before the termination of his or her employment becomes effective, the notice of intent to terminate will automatically be deemed to have been revoked.

(d)Good Reason. “Good Reason” will mean Executive’s termination of employment within ninety (90) days following the expiration of any cure period (discussed below) following the occurrence of one or more of the following, without Executive’s consent:

(i)A material reduction in Executive’s base compensation as in effect immediately prior to such reduction not including a substantially similar reduction that applies to similarly situated Executives;

(ii)The assignment to Executive of any duties, or the reduction of Executive’s duties, either of which results in a material diminution of Executive’s authority, duties, or responsibilities with the Company in effect immediately prior to such assignment, or the removal of Executive from such position and responsibilities, provided that such removal results in a material diminution of Executive’s authority, duties, or responsibilities with the Company; provided, however, that a reduction in duties, position or responsibilities solely by virtue of the Company being acquired and made part of a larger entity, whether as a subsidiary, business unit or otherwise (as, for example, when the Chief Executive Officer of the Company remains the Chief Executive Officer of the Company following a Change of Control where the Company becomes a wholly owned subsidiary of the acquiror, but is not made the Chief Executive Officer of the acquiring corporation) will not constitute “Good Reason;”

(iii)A material change in the geographic location at which Executive must perform services (in other words, the relocation of Executive to a facility that is more than fifty (50) miles from Executive’s current location); or

(iv)the failure of the Company to obtain the assumption of the Agreement by a successor and/or acquirer.

Executive will not resign for Good Reason without first providing the Company with written notice within, ninety (90) days of the event that Executive believes constitutes “Good Reason” specifically identifying the acts or omissions constituting the grounds for Good Reason and a reasonable cure period of not less than thirty (30) days following the date of such notice.
19



(e)Section 409A Limit. “Section 409A Limit” will mean the lesser of two (2) times: (i) Executive’s annualized compensation based upon the annual rate of pay paid to Executive during the Executive’s taxable year preceding the Executive’s taxable year of Executive’s termination of employment as determined under, and with such adjustments as are set forth in, Treasury Regulation 1.409A-1(b)(9)(iii)(A)(1) and any Internal Revenue Service guidance issued with respect thereto; or (ii) the maximum amount that may be taken into account under a qualified plan pursuant to Section 401(a)(17) of the Code for the year in which Executive’s employment is terminated.

7.Successors.

(a)The Company’s Successors. Any successor to the Company (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company’s business and/or assets will assume the obligations under this Agreement and agree expressly to perform the obligations under this Agreement in the same manner and to the same extent as the Company would be required to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company” will include any successor to the Company’s business and/or assets which executes and delivers the assumption agreement described in this Section 7(a) or which becomes bound by the terms of this Agreement by operation of law.

(b)Executive’s Successors. The terms of this Agreement and all rights of Executive hereunder will inure to the benefit of, and be enforceable by, Executive’s personal or legal representatives, executors, administrators, successors, heirs, distributees, devisees and legatees.

8.Notice.

(a)General. Notices and all other communications contemplated by this Agreement will be in writing and will be deemed to have been duly given when personally delivered when mailed by U.S. registered or certified mail, return receipt requested and postage prepaid or when delivered by a private courier service such as UPS, DHL or Federal Express that has tracking capability. In the case of Executive, mailed notices will be addressed to him or her at the home address which he or she most recently communicated to the Company in writing. In the case of the Company, mailed notices will be addressed to its corporate headquarters, and all notices will be directed to the attention of its Chief Executive Officer.

(b)Notice of Termination. Any termination by the Company for Cause or by Executive for Good Reason will be communicated by a notice of termination to the other party hereto given in accordance with Section e(a) of this Agreement. Such notice will indicate the specific termination provision in this Agreement relied upon, will set forth in reasonable detail the facts and circumstances claimed to provide a basis for termination under the provision so indicated, and will specify the termination date (which will be not more than ninety (90) days after the giving of such notice). The failure by Executive to include in the notice any fact or
20


circumstance which contributes to a showing of Good Reason will not waive any right of Executive hereunder or preclude Executive from asserting such fact or circumstance in enforcing his or her rights hereunder.

9.Miscellaneous Provisions.

(a)No Duty to Mitigate. Executive will not be required to mitigate the amount of any payment contemplated by this Agreement, nor will any such payment be reduced by any earnings that Executive may receive from any other source.

(b)Waiver. No provision of this Agreement will be modified, waived or discharged unless the modification, waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive). No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party will be considered a waiver of any other condition or provision or of the same condition or provision at another time.

(c)Headings. All captions and section headings used in this Agreement are for convenient reference only and do not form a part of this Agreement.

(d)Entire Agreement. This Agreement constitutes the entire agreement of the parties hereto and supersedes in their entirety all prior representations, understandings, undertakings or agreements (whether oral or written and whether expressed or implied) of the parties with respect to the subject matter hereof. No waiver, alteration, or modification of any of the provisions of this Agreement will be binding unless in writing and signed by duly authorized representatives of the parties hereto and which specifically mention this Agreement.
(e)Choice of Law. The validity, interpretation, construction and performance of this Agreement will be governed by the laws of the State of California (with the exception of its conflict of laws provisions). Any claims or legal actions by one party against the other arising out of the relationship between the parties contemplated herein (whether or not arising under this Agreement) will be commenced or maintained in any state or federal court located in the jurisdiction where Executive resides, and Executive and the Company hereby submit to the jurisdiction and venue of any such court.

(f)Severability. The invalidity or unenforceability of any provision or provisions of this Agreement will not affect the validity or enforceability of any other provision hereof, which will remain in full force and effect.

(g)Withholding. All payments made pursuant to this Agreement will be subject to withholding of applicable income, employment and other taxes.

(h)Counterparts and Electronic Signature. This This Agreement may be executed in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument. Delivery of an executed counterpart of this Agreement
21


by facsimile transmission or in portable document format or similar electronic form by email shall constitute due and effective delivery thereof.

[Signature Page to Follow]
IN WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as of June 14, 2021.

COMPANY    PLANTRONICS, INC.


By:     /s/ David Shull    

Name: David Shull

Title:    President & Chief Executive Officer    

Date:    _June 14, 2021__________________



EXECUTIVE     By:     /s/ Warren Schlichting    

Name: Warren Schlichting

Title:     Executive Vice President, Chief
Operating Officer

Date:     June 14, 2021    
22


Exhibit 31.1
Certification of the President and CEO
I, David M. Shull, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
July 30, 2021
/s/ David M. Shull
David M. Shull
President, Chief Executive Officer and Director




Exhibit 31.2
Certification of the Executive Vice President and CFO
I, Charles D. Boynton, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Plantronics, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.
July 30, 2021
/s/ Charles D. Boynton
Charles D. Boynton
Executive Vice President and Chief Financial Officer



Exhibit 32.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER
PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

I, David M. Shull, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Plantronics, Inc. on Form 10-Q for the period ended July 3, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Plantronics, Inc.
By: /s/ David M. Shull
Name: David M. Shull
Title: President, Chief Executive Officer and Director
Date: July 30, 2021

I, Charles D. Boynton, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Quarterly Report of Plantronics, Inc. on Form 10-Q for the period ended July 3, 2021 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Quarterly Report on Form 10-Q fairly presents in all material respects the financial condition and results of operations of Plantronics, Inc.
By: /s/ Charles D. Boynton
Name: Charles D. Boynton
Title: Executive Vice President and Chief Financial Officer
Date: July 30, 2021

This certification accompanies the Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.